Other and unspecified myopathies

G6_MYOPOTHUNS

myopathy: a disease of the muscle in which the muscle fibers do not function properly. This results in muscular weakness.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G72.8, G72.9 Hospital discharge: ICD-9 — 3594B\|359[8-9] Cause of death: ICD-10 — G72.8, G72.9 Cause of death: ICD-9 — 3594B\|359[8-9] 2 out of 7 registries used, show all original rules.	3279
4. Check minimum number of events None	3279
5. Include endpoints None	3279
6. Filter based on genotype QC (FinnGen only)	3279

Control definitions (FinnGen only)

Control exclude: G6_MYONEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	G6_MYOPOTHUNS
CONTROL_EXCLUDE	G6_MYONEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G72[8-9]
HD_ICD_9	3594B\|359[8-9]
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G72[8-9]
COD_ICD_9	3594B\|359[8-9]
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified myopathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31284	13661	17471
Only index persons	28306	12682	15624
Unadjusted period prevalence (%)
Whole population	0.44	0.39	0.49
Only index persons	0.54	0.47	0.60
Median age at first event (years)
Whole population	68.48	74.18	64.03
Only index persons	68.82	74.39	64.29

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3279	1346	1933
Unadjusted period prevalence (%)	0.69	0.46	0.85
Median age at first event (years)	64.76	64.27	65.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2918: Matched controls
29180

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G72.8

ICD-10 Finland

Other specified myopathies

11315.6

323.0

2074

G72.9

ICD-10 Finland

Myopathy, unspecified

7329.4

323.0

1007

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.5

228.2

1007

3075

AA1AD

NOMESCO Finland

CT of head and brain

3.7

203.0

1215

4762

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.8

191.3

529

922

N05AH04

ATC

quetiapine; oral

3.7

147.0

760

2517

L28

ICPC

Limited function/disability (L)

3.5

143.3

813

2892

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.9

141.6

1261

6141

T36

ICD-10 Finland

Poisoning by systemic antibiotics

8.2

137.0

325

441

N05AH03

ATC

olanzapine; systemic

6.1

126.2

371

680

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.7

123.0

334

550

A28

ICPC

Limited function/disability NOS

3.2

122.4

771

2918

NXL00

NOMESCO Finland

Biopsy of muscle

92.2

119.1

132

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.8

118.8

435

1025

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.6

109.7

573

1862

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

8.5

106.6

244

309

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

103.5

724

2898

N03AG01

ATC

valproic acid; systemic, rectal

5.3

101.5

337

707

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.6

101.0

316

619

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

99.0

1002

4989

R53

ICD-10 Finland

Malaise and fatigue

2.7

97.3

844

3841

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.1

97.2

425

1177

N05BA01

ATC

diazepam; systemic, rectal

3.1

96.3

613

2285

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

55.4

94.1

112

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

60.1

93.7

110

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.9

93.0

681

2783

N05AA02

ATC

levomepromazine; systemic

5.6

92.1

287

557

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.6

91.2

472

1503

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.2

90.2

376

993

N06AX11

ATC

mirtazapine; oral

2.3

89.2

1085

5869

N05BA04

ATC

oxazepam; oral

2.5

89.0

899

4415

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

7.8

87.2

210

287

N05AX08

ATC

risperidone; systemic

3.6

84.6

419

1283

SPAT1216

SPAT

Assessment of functional ability

2.7

82.8

681

2958

SPAT1254

SPAT

Administration of medicine

2.8

82.0

636

2667

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

38.5

81.6

104

N05CD07

ATC

temazepam; oral

2.8

81.6

598

2421

C03CA01

ATC

furosemide; systemic

2.2

80.4

1143

6574

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

788.8

78.7

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

5.0

77.8

265

567

N03AE01

ATC

clonazepam; systemic

4.3

77.5

315

807

N03AX16

ATC

pregabalin; oral

2.4

75.6

817

4092

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.6

75.5

170

208

L89

ICD-10 Finland

Decubitus ulcer and pressure area

8.9

75.1

165

194

N06AB04

ATC

citalopram; systemic

2.4

74.6

773

3787

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

74.0

553

2250

G71.08

ICD-10 Finland

Other muscular dystrophy

+∞

72.2

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

11.7

71.8

136

121

SPAT1229

SPAT

Assessment of need for aid

3.3

71.7

398

1322

M60.9

ICD-10 Finland

Myositis, unspecified

23.7

71.4

103

F10.25

ICD-10 Finland

Alcohol dependence continuous use

9.1

71.2

155

179

N05AF03

ATC

chlorprothixene; systemic

7.1

70.4

180

268

P15

ICPC

Chronic alcohol abuse

6.5

66.6

182

297

SPAT1234

SPAT

Support of social functional capacity

4.0

66.2

289

787

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

65.4

659

3150

N07BB01

ATC

disulfiram; oral

4.5

64.1

241

569

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

64.1

571

2552

M33.2

ICD-10 Finland

Polymyositis

63.2

63.7

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

8.4

61.6

140

174

N03AX12

ATC

gabapentin; oral

2.5

61.5

545

2422

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

61.1

384

1384

N05CF01

ATC

zopiclone; oral

2.0

60.9

1084

6642

F10.24

ICD-10 Finland

Alcohol depence active use

8.9

59.3

130

152

W19

ICD-10 Finland

Unspecified fall

2.8

56.8

397

1531

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.1

55.8

159

274

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

55.6

276

834

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

55.5

514

2328

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.4

55.2

291

921

X59

ICD-10 Finland

Exposure to unspecified factor

2.3

55.1

630

3171

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

9.2

55.0

118

133

S01.0

ICD-10 Finland

Open wound of scalp

3.0

54.9

345

1237

A04

ICPC

Weakness/tiredness general

2.5

54.3

485

2153

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

14.8

54.2

A46

ICD-10 Finland

Erysipelas

2.4

53.9

541

2552

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

53.9

1378

9509

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

19.6

53.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.2

52.4

297

991

M60.8

ICD-10 Finland

Other myositis

39.7

52.4

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.4

52.4

201

483

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.1

52.4

133

196

N03AX09

ATC

lamotrigine; oral

4.6

51.4

187

426

R1250

NOMESCO Finland

Evaluation of functional capability

6.8

51.4

134

205

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

50.7

1006

6310

N05BA02

ATC

chlordiazepoxide; systemic

5.6

50.6

154

288

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.4

50.2

477

2179

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.0

49.8

168

353

E86

ICD-10 Finland

Volume depletion

5.0

49.4

165

343

SPAT1172

SPAT

Guidance concerning hydration

5.4

49.2

155

302

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.7

49.0

129

200

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

48.8

338

1290

A06AD11

ATC

lactulose; oral

2.2

48.6

563

2830

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

48.5

353

1386

N05AH02

ATC

clozapine; systemic

7.4

47.4

116

162

S06.0

ICD-10 Finland

Concussion

2.6

47.1

381

1592

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.1

46.6

131

222

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.0

46.5

196

514

F05.9

ICD-10 Finland

Delirium, unspecified

5.6

46.4

141

263

N06AX16

ATC

venlafaxine; oral

2.5

46.2

419

1861

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.9

46.2

303

1115

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

46.1

470

2216

N05BA06

ATC

lorazepam; systemic, sublingual

3.3

45.8

246

787

G72.0

ICD-10 Finland

Drug-induced myopathy

+∞

44.9

R60.0

ICD-10 Finland

Localized oedema

2.5

44.5

398

1755

N99

ICPC

Neurological disease other

9.1

44.1

108

F20.9

ICD-10 Finland

Schizophrenia, unspecified

6.1

44.1

124

210

N06AX21

ATC

duloxetine; oral

2.6

44.1

344

1406

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

43.7

228

713

N04AA02

ATC

biperiden; systemic

6.1

42.4

120

205

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

6.3

42.4

116

190

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.6

41.8

197

568

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.6

41.8

126

233

N17.8

ICD-10 Finland

Other acute renal failure

8.1

41.5

120

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.2

41.3

166

416

A41.9

ICD-10 Finland

Sepsis, unspecified

3.8

41.3

187

522

N06AA09

ATC

amitriptyline; systemic

2.5

40.9

354

1530

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

+∞

40.7

N06AB06

ATC

sertraline; oral

2.5

40.1

335

1420

N05BA12

ATC

alprazolam; oral

2.5

39.9

351

1529

A02BC02

ATC

pantoprazole; systemic

1.7

39.9

1830

14532

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

39.7

861

5463

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.0

39.5

132

275

N05BE01

ATC

buspirone; oral

4.5

38.5

141

323

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

8.4

38.4

105

N05AD01

ATC

haloperidol; systemic

4.0

38.3

161

421

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

38.2

371

1698

S97

ICPC

Chronic ulcer skin

3.1

38.1

228

786

T68

ICD-10 Finland

Hypothermia

17.0

37.6

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

9.1

37.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

37.3

878

5696

N29

ICPC

Neurological sympt/complt other

5.8

37.2

108

191

N02AX02

ATC

tramadol; systemic, rectal

1.7

37.1

1232

8855

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.2

37.0

147

365

N28

ICPC

Limited function/disability (N)

5.8

36.6

107

191

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

36.3

209

702

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

36.2

250

946

TK800

NOMESCO Finland

Hemodialysis

4.8

36.2

125

270

N02BE01

ATC

paracetamol; systemic, rectal

1.8

36.0

2413

21066

R41.0

ICD-10 Finland

Disorientation, unspecified

3.7

35.9

165

466

N05AX12

ATC

aripiprazole; systemic

4.2

35.8

141

347

C07AB07

ATC

bisoprolol; oral

1.6

35.7

1440

10878

M62.9

ICD-10 Finland

Disorder of muscle, unspecified

22.0

35.7

E87.6

ICD-10 Finland

Hypokalaemia

3.9

35.5

151

399

WX892

NOMESCO Finland

Monitored bed care

2.5

35.5

293

1231

N06AB03

ATC

fluoxetine; oral

2.2

35.3

383

1845

SPAT1301

SPAT

No procedures

1.7

35.0

947

6382

N05AB03

ATC

perphenazine; systemic, rectal

3.8

34.8

153

416

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.1

34.5

204

697

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

8.0

34.3

101

N05AC02

ATC

thioridazine; oral

5.4

34.2

106

203

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

34.0

458

2423

Z72.1

ICD-10 Finland

Alcohol use

7.3

33.8

117

N02AA05

ATC

oxycodone; systemic

2.0

33.6

493

2697

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

33.6

281

1186

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

33.6

557

3192

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.8

33.4

147

400

NF1AA

NOMESCO Finland

Hip X-ray examination

2.4

33.4

302

1329

3599X

ICD-9 Finland

Muscular dystrophies and other myopathies, Myopathy, unspecified

+∞

33.4

N05AN01

ATC

lithium; oral

4.8

33.0

113

242

N05CF02

ATC

zolpidem; oral

2.0

32.8

492

2715

N05AA01

ATC

chlorpromazine; systemic, rectal

6.6

32.4

132

N06AB10

ATC

escitalopram; oral

1.9

32.4

510

2861

G71.8

ICD-10 Finland

Other primary disorders of muscles

+∞

32.3

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.6

32.3

252

1025

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.8

32.2

222

838

P72

ICPC

Schizophrenia

5.9

32.0

161

N06AX03

ATC

mianserin; oral

3.1

31.9

184

618

G71.18

ICD-10 Finland

Other myotonic disease

320.4

31.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

31.7

251

1028

TKC20

NOMESCO Finland

Catheterisation of bladder

2.4

31.4

278

1206

N03AF01

ATC

carbamazepine; oral, rectal

2.9

31.2

206

757

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

31.2

630

3854

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.4

31.1

132

C07AA05

ATC

propranolol; systemic

1.9

31.1

519

2973

SPAT1240

SPAT

Therapeutic discussion

2.5

30.8

266

1140

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

30.8

454

2481

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

30.7

477

2658

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

7.8

30.5

SPAT1167

SPAT

Insertion of urinary catheter

3.4

30.4

155

476

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.8

30.1

116

P29

ICPC

Psychological sympt/compl other

3.2

29.9

163

526

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.3

29.8

313

1478

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

29.7

482

2727

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.6

29.1

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

28.9

217

861

N06AA12

ATC

doxepin; systemic

2.7

28.8

209

811

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

8.8

28.7

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

28.6

343

1718

M79.6

ICD-10 Finland

Pain in limb

1.6

28.6

936

6571

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.7

28.3

128

357

T79.6

ICD-10 Finland

Traumatic ischaemia of muscle

20.3

28.2

TAB00

NOMESCO Finland

Lumbar puncture

3.2

28.2

155

504

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

8.1

28.1

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

27.9

314

1529

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.0

27.8

186

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.7

27.7

193

733

R50.9

ICD-10 Finland

Fever, unspecified

1.9

27.5

424

2349

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.6

27.5

220

P99

ICPC

Psychological disorders other

4.5

27.2

227

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.3

27.0

142

447

N03AX14

ATC

levetiracetam; systemic

4.1

26.9

108

272

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

26.8

167

591

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.0

26.7

110

283

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

26.6

148

485

L19

ICPC

Muscle symptom/complaint NOS

4.2

26.6

105

260

TNX05

NOMESCO Finland

Simple incision of soft tissue, unspecified region

22.6

26.5

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

12.2

26.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

26.4

230

989

SPAT1263

SPAT

Sampling

1.5

26.4

1150

8622

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

26.4

203

818

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.8

26.2

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

26.2

231

999

V03AA01

ATC

4.8

26.2

190

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

60.6

26.0

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.0

25.9

153

521

G72

ICD-10 Finland

Other myopathies

262.8

25.7

A29

ICPC

General symptom/complaint other

2.0

25.4

343

1804

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

25.3

203

837

N18

ICPC

Paralysis/weakness

4.4

25.2

221

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

20.8

25.2

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.4

25.2

P16

ICPC

Acute alcohol abuse

5.2

25.1

155

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

25.1

487

2916

N07AA02

ATC

pyridostigmine; systemic

30.3

25.0

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

8.3

24.8

S18

ICPC

Laceration/cut

1.5

24.7

1138

8602

Y94.0

ICD-10 Finland

Accident at home

4.4

24.5

213

L99

ICPC

Musculoskeletal disease other

4.5

24.5

204

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.7

24.5

186

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

24.3

276

1349

Z72.2

ICD-10 Finland

Drug use

15.0

24.2

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

24.2

299

1513

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

24.1

357

1943

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

24.1

341

1821

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

24.0

179

708

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.0

23.8

156

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.6

23.8

186

754

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.1

23.7

138

467

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

7.5

23.6

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

41.8

23.6

M62.8

ICD-10 Finland

Other specified disorders of muscle

18.2

23.5

R55

ICD-10 Finland

Syncope and collapse

1.9

23.4

351

1916

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

23.4

203

873

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

6.2

23.3

103

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

6.1

23.3

107

R13

ICD-10 Finland

Dysphagia

2.4

23.2

215

953

R4110

NOMESCO Finland

Physiotherapy

1.6

23.2

728

5003

G72.4

ICD-10 Finland

Inflammatory myopathy, not elsewhere classified

+∞

22.9

G71.11

ICD-10 Finland

Dystrophia myotonica [Steinert]

+∞

22.9

X58

ICD-10 Finland

Exposure to other specified factors

1.9

22.9

371

2083

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

13.1

22.9

R33

ICD-10 Finland

Retention of urine

2.1

22.9

279

1405

G70.0

ICD-10 Finland

Myasthenia gravis

231.6

22.6

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

22.5

113

344

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

22.5

207

915

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.4

22.4

194

R42

ICD-10 Finland

Dizziness and giddiness

1.6

22.4

616

4080

F61.0

ICD-10 Finland

Mixed personality disorders

5.7

22.3

117

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

22.2

238

1131

R06.0

ICD-10 Finland

Dyspnoea

1.6

22.1

683

4663

Z02.7

ICD-10 Finland

Issue of medical certificate

2.4

22.1

189

807

N06AA06

ATC

trimipramine; systemic

3.7

22.0

271

F34.1

ICD-10 Finland

Dysthymia

3.4

21.9

109

330

ZZA00

NOMESCO Finland

Split skin graft

3.1

21.9

126

424

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.6

21.9

278

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

21.8

286

1482

J01DB01

ATC

cefalexin; oral

1.5

21.8

2188

19320

A01

ICPC

Pain general/multiple sites

2.2

21.5

232

1107

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

21.5

470

2910

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

15.4

21.5

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

12.0

21.5

S22.3

ICD-10 Finland

Fracture of rib

2.3

21.4

213

976

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.9

21.4

149

N05AF05

ATC

zuclopenthixol; systemic

5.9

21.3

104

K08.3

ICD-10 Finland

Retained dental root

2.2

21.2

224

1056

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.3

21.2

125

WX730

NOMESCO Finland

Conventional respirator

4.3

21.1

183

188

Kela drug reimbursment

Psychosis requiring demanding treatment

6.0

21.0

E0000UV

ATC

1.5

21.0

991

7458

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

20.9

681

4701

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

11.0

20.6

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.0

20.5

G41.9

ICD-10 Finland

Status epilepticus, unspecified

8.3

20.4

J01FF01

ATC

clindamycin; systemic

1.6

20.3

713

5008

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.8

20.3

N06AX05

ATC

trazodone; oral

3.8

20.3

234

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

15.1

20.2

M48.0

ICD-10 Finland

Spinal stenosis

1.8

20.2

359

2078

N30.0

ICD-10 Finland

Acute cystitis

1.8

20.1

362

2102

SPAT1262

SPAT

Handing over of treatment supplies

1.6

20.1

534

3488

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.7

20.1

246

N05AL01

ATC

sulpiride; systemic

4.6

20.1

155

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

19.9

229

1121

F51.0

ICD-10 Finland

Nonorganic insomnia

1.9

19.9

301

1647

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.3

19.9

175

WX872

NOMESCO Finland

Intensive care

2.4

19.7

176

767

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.8

19.4

218

M79.1

ICD-10 Finland

Myalgia

1.9

19.4

319

1800

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.4

19.4

296

XA402

NOMESCO Finland

ENMG

3.6

19.3

249

M54.5

ICD-10 Finland

Low back pain

1.5

19.3

790

5737

C03DA01

ATC

spironolactone; oral

1.8

19.1

327

1868

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

18.9

101

323

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

18.9

132

503

H02AB06

ATC

prednisolone; systemic

1.4

18.7

1223

9763

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.3

18.7

162

J01MA12

ATC

levofloxacin; systemic

1.6

18.6

535

3562

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

18.6

816

6006

SPAT1251

SPAT

Organisation of medication

2.6

18.6

137

537

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.5

18.5

253

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

4.6

18.5

141

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.3

18.4

172

766

P01

ICPC

Feeling anxious/nervous/tense

2.2

18.3

197

936

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

18.3

218

1086

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.2

18.3

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

11.9

18.3

SPAT1265

SPAT

Breathalyser

5.7

18.3

EBA00

NOMESCO Finland

Extraction of tooth

1.5

18.2

809

5966

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.2

18.1

301

WX110

NOMESCO Finland

Local anesthesy

1.4

18.1

1695

14441

S00.0

ICD-10 Finland

Superficial injury of scalp

3.6

18.0

233

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

18.0

211

1045

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

17.9

250

1324

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

17.8

242

1271

Z08

ICPC

Social welfare problem

5.2

17.7

108

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

17.6

304

1737

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

17.6

557

3799

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

17.6

291

1639

N05AB01

ATC

dixyrazine; systemic

4.5

17.5

140

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.1

17.4

329

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.6

17.3

N03AF02

ATC

oxcarbazepine; oral

2.9

17.3

108

385

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

21.0

17.3

F31

ICD-10 Finland

Bipolar affective disorder

5.4

17.2

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.8

17.1

113

416

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.1

17.1

196

961

P20

ICPC

Memory disturbance

1.7

17.0

374

2313

A02BC01

ATC

omeprazole; systemic

1.5

16.9

748

5496

SPAT1252

SPAT

Overall medication plan or its review

2.0

16.9

220

1136

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

16.9

278

N06AX26

ATC

vortioxetine; oral

2.4

16.8

148

641

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

6.0

16.8

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

16.8

691

5003

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.5

16.8

136

564

G72.1

ICD-10 Finland

Alcoholic myopathy

+∞

16.7

G71.00

ICD-10 Finland

Muscular dystrophy benign [Becker]

+∞

16.7

SPAT1125

SPAT

Stoma care and guidance

3.7

16.7

196

H02AB09

ATC

hydrocortisone; systemic

3.5

16.6

227

WX882

NOMESCO Finland

High dependency care

3.0

16.6

337

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.4

16.6

243

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.9

16.6

182

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

6.4

16.5

N05CD02

ATC

nitrazepam; oral

3.4

16.5

234

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

16.4

165

763

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

10.1

16.4

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

16.3

368

2288

A02BC05

ATC

esomeprazole; systemic

1.4

16.2

1010

7929

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

10.4

16.2

R4120

NOMESCO Finland

Occupational therapy

2.1

16.0

179

867

N06AX12

ATC

bupropion; oral

2.4

16.0

135

572

R51.80

ICD-10 Finland

Headache

1.7

15.9

335

2040

R40.2

ICD-10 Finland

Coma, unspecified

5.3

15.9

S70.0

ICD-10 Finland

Contusion of hip

2.5

15.9

128

531

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

15.8

688

5027

E87.2

ICD-10 Finland

Acidosis

6.8

15.7

L76

ICPC

Fracture: other

2.8

15.7

100

360

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

13.0

15.6

G71.28

ICD-10 Finland

Other congenital myopathy

+∞

15.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

15.6

762

5698

S01.9

ICD-10 Finland

Open wound of head, part unspecified

3.8

15.6

172

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.4

15.5

T51.0

ICD-10 Finland

Toxic effect: Ethanol

10.8

15.4

U04

ICPC

Incontinence urine

2.3

15.4

145

650

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

10.1

15.4

P76

ICPC

Depressive disorder

2.4

15.4

131

559

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

15.3

286

1677

X31

ICD-10 Finland

Exposure to excessive natural cold

12.4

15.3

P03

ICPC

Feeling depressed

2.1

15.3

181

900

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

15.3

100

368

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

15.2

1607

13768

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

11.3

15.2

SPAT1211

SPAT

Application of soft bandage

1.9

15.2

246

1375

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

15.2

960

7531

N06AB05

ATC

paroxetine; oral

2.2

15.2

151

693

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.1

15.2

142

F22.0

ICD-10 Finland

Delusional disorder

3.9

15.1

157

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.0

15.1

295

SPAT1139

SPAT

Nutrition survey

2.7

14.9

104

395

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

14.9

205

1080

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

14.9

209

1110

S43.0

ICD-10 Finland

Dislocation of shoulder joint

2.6

14.9

112

447

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.8

14.9

350

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

7.6

14.9

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

14.8

621

4490

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.5

14.8

118

486

W10

ICD-10 Finland

Fall on and from stairs and steps

2.3

14.8

139

624

SPAT1243

SPAT

Psychiatric/psychological examination

3.5

14.8

201

N06AG02

ATC

moclobemide; oral

2.4

14.8

129

556

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

14.7

648

4738

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

8.7

14.7

M33.1

ICD-10 Finland

Other dermatomyositis

25.1

14.7

P18

ICPC

Medication abuse

6.9

14.7

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

21.1

14.6

NFM10

NOMESCO Finland

Fasciotomy of thigh

21.1

14.6

F20

ICD-10 Finland

Schizophrenia

7.1

14.6

SPAT1053

SPAT

Memory test

1.6

14.5

446

3007

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

14.4

422

2811

AA1XD

NOMESCO Finland

Other special CT of head and brain

8.9

14.4

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

8.9

14.4

M05BA04

ATC

alendronic acid; oral

1.8

14.4

243

1380

J01MA02

ATC

ciprofloxacin; systemic

1.4

14.4

1038

8318

D21

ICPC

Swallowing problem

4.1

14.4

140

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.2

14.4

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

14.3

158

763

Z29

ICPC

Social problem NOS

3.4

14.2

202

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

14.2

306

1872

K07

ICPC

Swollen ankles/oedema

2.3

14.2

132

589

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

22.4

14.2

C08CA01

ATC

amlodipine; oral

1.4

14.2

974

7736

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.2

14.1

128

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.1

14.1

133

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

14.1

160

782

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

14.0

116

488

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.9

14.0

144

N06AA10

ATC

nortriptyline; systemic

3.4

13.9

195

L17

ICPC

Foot/toe symptom/complaint

1.5

13.9

616

4503

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

13.9

134

607

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.0

13.8

267

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

8.2

13.8

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

8.2

13.8

M03BX01

ATC

baclofen; systemic

3.8

13.8

151

P28

ICPC

Limited function/disability (P)

6.0

13.7

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.7

13.7

349

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

8.6

13.7

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

13.6

13.7

L04AX01

ATC

azathioprine; systemic

2.3

13.6

122

534

G62.8

ICD-10 Finland

Other specified polyneuropathies

5.1

13.6

Z31.5

ICD-10 Finland

Genetic counselling

2.5

13.6

107

438

J01DA01

ATC

[U] cefalexin; systemic

1.3

13.6

1607

13901

TK810

NOMESCO Finland

Hemofiltration

6.2

13.6

X57

ICD-10 Finland

Unspecified privation

3.2

13.6

232

NC2AA

NOMESCO Finland

Forearm X-ray examination

4.8

13.6

108

Kela drug reimbursment

Myasthenia gravis

+∞

13.5

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

10.9

13.5

H25.8

ICD-10 Finland

Other senile cataract

1.7

13.5

309

1928

B01AA03

ATC

warfarin; systemic

1.5

13.5

612

4491

F03

ICD-10 Finland

Unspecified dementia

2.1

13.5

147

707

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.1

13.4

WYA20

NOMESCO Finland

Home visit

3.5

13.4

185

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

12.9

13.4

EBA30

NOMESCO Finland

Excision of root of tooth

2.1

13.3

157

779

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

13.3

344

2219

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

13.2

101

406

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

13.2

834

6508

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

13.2

563

4079

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

13.2

158

790

SPAT1360

SPAT

Extensive global examination

1.9

13.1

208

1156

N05CD08

ATC

midazolam; nasal, systemic

2.9

13.0

284

L75

ICPC

Fracture: femur

3.8

13.0

144

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

16.8

13.0

G12.8

ICD-10 Finland

Other spinal muscular atrophies and related syndromes

28.5

12.9

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.5

12.9

175

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

12.9

125

568

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

13.0

12.9

X84

ICD-10 Finland

Intentional self-harm by unspecified means

19.1

12.9

SPAT1227

SPAT

Substance abuse rehabilitation

6.1

12.8

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

12.8

265

1601

R11

ICD-10 Finland

Nausea and vomiting

1.9

12.8

205

1141

N88

ICPC

Epilepsy

8.1

12.8

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

12.7

172

903

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

12.7

116

513

N05AD03

ATC

melperone; systemic

3.6

12.7

157

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

12.7

264

1601

A41.8

ICD-10 Finland

Other specified sepsis

3.3

12.7

194

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

7.5

12.7

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

12.6

339

2206

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

12.6

400

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

12.5

318

2036

R52.1

ICD-10 Finland

Chronic intractable pain

5.7

12.5

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.5

12.5

G71.25

ICD-10 Finland

Congenital muscular dystrophy NOS

+∞

12.5

K92.0

ICD-10 Finland

Haematemesis

2.6

12.5

341

G70.9

ICD-10 Finland

Myoneural disorder, unspecified

130.5

12.4

G71.0

ICD-10 Finland

Muscular dystrophy

130.5

12.4

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.2

12.4

197

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

12.4

336

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.3

12.4

192

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.8

12.4

298

N87

ICPC

Parkinsonism

3.4

12.4

176

RS221

NOMESCO Finland

3.7

12.4

145

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

12.3

1133

9376

C09AA05

ATC

ramipril; oral

1.4

12.3

688

5244

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.1

12.2

216

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.3

12.2

103

H53.2

ICD-10 Finland

Diplopia

2.6

12.2

344

RS220

NOMESCO Finland

3.9

12.2

127

A10BA02

ATC

metformin; oral

1.4

12.2

738

5703

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

12.2

267

1643

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

5.1

12.1

R03BB04

ATC

tiotropium bromide; inhalant

1.7

12.0

282

1770

M62.5

ICD-10 Finland

Muscle wasting and atrophy, not elsewhere classified

11.1

12.0

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

12.0

294

1864

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

6.0

11.9

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

11.9

169

903

Z50.1

ICD-10 Finland

Other physical therapy

2.0

11.9

149

761

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.5

11.9

161

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.5

11.8

356

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

6.1

11.8

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

11.7

132

644

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.9

11.7

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.2

11.7

190

L03

ICPC

Low back symptom/complaint

1.4

11.7

532

3893

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.5

11.7

153

L29

ICPC

Musculoskeletal sympt/complt other

1.8

11.6

194

1098

E000001

ATC

1.5

11.6

487

3507

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.4

11.6

100

429

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

11.6

138

SPAT1127

SPAT

Enema

4.7

11.6

G12.2

ICD-10 Finland

Motor neuron disease

6.9

11.6

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.7

11.5

306

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.8

11.5

124

NF3AA

NOMESCO Finland

Femur X-ray examination

2.9

11.5

237

J96.1

ICD-10 Finland

Chronic respiratory failure

2.7

11.5

290

G56.3

ICD-10 Finland

Lesion of radial nerve

5.3

11.5

NJ3CM

NOMESCO Finland

Extensive MRI examination of extremities with 3 Tesla magnet

+∞

11.5

Z03

ICPC

Housing/neighbourhood problem

5.7

11.5

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

13.6

11.4

E000003

ATC

2.2

11.4

115

534

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

11.4

127

618

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

6.0

11.3

F25

ICD-10 Finland

Schizoaffective disorders

11.8

11.3

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

11.2

258

1608

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

11.2

126

615

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

11.2

114

533

F21

ICPC

4.7

11.2

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.0

11.2

208

H02AB07

ATC

prednisone; oral

1.5

11.2

357

2421

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.3

11.2

428

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.4

11.2

419

N03AB02

ATC

phenytoin; systemic

3.7

11.1

128

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.9

11.1

G04BD08

ATC

solifenacin; oral

1.8

11.0

183

1032

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

11.0

256

1600

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

11.0

765

6031

OAB43

SPAT

0.5

11.0

1746

UJF32

NOMESCO Finland

Coloscopy

1.4

11.0

650

4987

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.8

11.0

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.0

11.0

215

30188

ICD-8 Finland

Personality disorders, Alia definita

6.6

10.9

F20.0

ICD-10 Finland

Paranoid schizophrenia

5.0

10.9

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.4

10.9

380

N19

ICD-10 Finland

Unspecified kidney failure

2.2

10.8

104

474

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

11.9

10.8

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

15.5

10.8

K90

ICPC

Stroke/cerebrovascular accident

2.4

10.8

395

X78

ICD-10 Finland

Intentional self-harm by sharp object

8.3

10.8

T90

ICPC

Diabetes non-insulin dependent

1.4

10.8

595

4513

D12

ICPC

Constipation

2.3

10.7

428

A99

ICPC

Disease/condition unspecnature/site

1.8

10.7

193

1122

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

10.7

276

1774

K85

ICD-10 Finland

Acute pancreatitis

3.0

10.7

198

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

10.7

256

N05AE04

ATC

ziprasidone; systemic

7.5

10.6

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

12.9

10.6

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.1

10.6

188

A08

ICPC

Swelling

2.1

10.6

116

559

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

11.2

10.5

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

8.5

10.5

R52.2

ICD-10 Finland

Other chronic pain

2.3

10.5

407

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

10.5

320

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.9

10.4

218

G71.02

ICD-10 Finland

Muscular dystrophy facioscapulohumeral

110.4

10.4

G72.2

ICD-10 Finland

Myopathy due to other toxic agents

+∞

10.4

JN4AD

NOMESCO Finland

Body CT examination

1.7

10.4

197

1160

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

10.4

835

6728

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

16.1

10.3

M79.7

ICD-10 Finland

Fibromyalgia

2.7

10.3

249

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

5.0

10.3

P19

ICPC

Drug abuse

5.0

10.3

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

8.2

10.3

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

10.3

344

2359

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.3

10.3

387

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.2

10.2

159

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

10.2

179

1031

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.7

10.1

240

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

5.9

10.1

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.5

10.1

129

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.8

10.1

109

G20

ICD-10 Finland

Parkinson disease

2.2

10.1

104

492

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.3

10.1

385

L14

ICPC

Leg/thigh symptom/complaint

1.8

10.1

175

1007

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

10.1

10.0

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

10.0

714

5643

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

14.6

10.0

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

10.0

230

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

40.2

10.0

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

9.9

304

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

9.9

935

7698

J01EA01

ATC

trimethoprim; systemic

1.4

9.9

572

4362

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.9

9.9

208

SPAT1260

SPAT

Consultation of another employee

1.4

9.9

426

3080

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.9

9.9

101

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.9

9.9

196

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

9.9

114

565

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

9.9

180

1050

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.4

9.8

344

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

26.1

9.8

N03AX11

ATC

topiramate; oral

3.0

9.8

176

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

10.6

9.8

A07AA09

ATC

vancomycin; oral

3.4

9.7

133

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.1

9.7

AA400

NOMESCO Finland

Electroconvulsive therapy

4.6

9.7

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.4

9.7

341

R27.0

ICD-10 Finland

Ataxia, unspecified

6.1

9.7

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.9

9.7

200

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

55.2

9.6

A10AE04

ATC

insulin glargine; parenteral

1.6

9.6

242

1545

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

3.7

9.6

109

Z00.0

ICD-10 Finland

General medical examination

1.4

9.6

439

3207

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

9.6

462

Z72.0

ICD-10 Finland

Tobacco use

2.7

9.6

231

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

9.5

261

1704

29999

ICD-8 Finland

Unspecified psychosis

6.4

9.5

F20.5

ICD-10 Finland

Residual schizophrenia

5.2

9.5

D07AC01

ATC

betamethasone; topical

1.3

9.5

809

6558

P74

ICPC

Anxiety disorder/anxiety state

2.4

9.5

319

NK1AK

NOMESCO Finland

Spectroscopy of muscles

100.3

9.4

S20.2

ICD-10 Finland

Contusion of thorax

2.0

9.4

125

653

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

3.0

9.4

185

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

30.1

9.4

G71.03

ICD-10 Finland

Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker

+∞

9.4

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

12.4

9.3

V03AA02

ATC

21.7

9.3

N03AX18

ATC

lacosamide; systemic

5.6

9.3

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.5

9.3

117

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.9

9.3

140

765

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

10.7

9.3

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

4.9

9.3

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.3

9.3

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

3.0

9.2

181

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

9.2

196

1196

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

9.2

189

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

7.3

9.2

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.1

9.2

450

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

13.7

9.2

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

13.7

9.2

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

9.2

194

1183

IGV01

NOMESCO Finland

Psychiatric network contact

4.8

9.1

N06AB08

ATC

fluvoxamine; oral

2.5

9.1

287

S06.3

ICD-10 Finland

Focal brain injury

3.3

9.1

135

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

9.1

252

1650

5CM18

NOMESCO Finland

6.7

9.1

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

9.1

320

2214

N06DA02

ATC

donepezil; oral

1.8

9.1

164

953

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

8.3

9.1

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

8.3

9.1

F32

ICD-10 Finland

Depressive episode

2.1

9.0

103

507

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

9.0

129

695

G40

ICD-10 Finland

Epilepsy

4.2

9.0

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.3

9.0

136

RS142

NOMESCO Finland

15.6

9.0

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

9.0

669

5307

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

4.7

9.0

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

10.0

9.0

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.7

9.0

223

N04BC05

ATC

pramipexole; oral

1.7

8.9

182

1099

RS222

NOMESCO Finland

3.3

8.9

132

E51.2

ICD-10 Finland

Wernicke encephalopathy

18.6

8.9

F20.10

ICD-10 Finland

Raise schizophrenia continuously

6.1

8.9

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.7

8.9

101

P27

ICPC

Fear of mental disorder

4.2

8.9

JN4BD

NOMESCO Finland

Extensive body CT

1.5

8.9

276

1861

K59.0

ICD-10 Finland

Constipation

1.8

8.8

153

877

M54.1

ICD-10 Finland

Radiculopathy

2.1

8.8

445

R25.2

ICD-10 Finland

Cramp and spasm

2.6

8.8

237

RD210

NOMESCO Finland

2.9

8.8

177

M25.5

ICD-10 Finland

Pain in joint

1.3

8.8

599

4686

G04BD12

ATC

mirabegron; oral

1.6

8.8

256

1700

SPAT1101

SPAT

Orthostatic test

1.9

8.8

134

738

XG466

NOMESCO Finland

Sleep oxymetry

2.1

8.8

426

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

8.8

274

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.4

8.6

296

WZA90

NOMESCO Finland

Other doctors statement

1.4

8.6

488

3698

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

8.6

387

2816

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

7.6

8.6

Z50.5

ICD-10 Finland

Speech therapy

3.7

8.6

UKC02

NOMESCO Finland

Cystoscopy

1.4

8.6

435

3233

F33.8

ICD-10 Finland

Other recurrent depressive disorders

6.1

8.6

XA400

NOMESCO Finland

EEG

5.2

8.6

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

8.6

185

1134

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.0

8.6

167

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

8.6

455

3413

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

8.5

163

967

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.1

8.5

148

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.8

8.5

182

F10.05

ICD-10 Finland

Alcohol-related acute intoxication with coma

10.0

8.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

8.5

389

2841

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

8.5

641

5095

G82.2

ICD-10 Finland

Paraplegia, unspecified

6.4

8.5

J01MA14

ATC

moxifloxacin; systemic

1.6

8.5

202

1276

E66.8

ICD-10 Finland

Other obesity

2.1

8.5

468

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

8.5

164

977

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.7

8.5

213

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

2.0

8.4

108

560

WX320

NOMESCO Finland

Spinalanesthesy

1.4

8.4

531

4100

F21

ICD-10 Finland

Schizotypal disorder

5.6

8.4

S82.1

ICD-10 Finland

Fracture of upper end of tibia

2.9

8.4

172

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.2

8.4

128

Z28

ICPC

Limited function/disability (Z)

4.8

8.4

L16

ICPC

Ankle symptom/complaint

1.6

8.4

215

1385

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

7.9

8.3

A02BA02

ATC

ranitidine; systemic

1.4

8.3

490

3741

G71.12

ICD-10 Finland

Myotonia congenita

+∞

8.3

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.3

496

3796

H02AB04

ATC

methylprednisolone; systemic

1.5

8.3

329

2336

R02

ICPC

Shortness of breath/dyspnoea

1.5

8.3

280

1922

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

5.0

8.3

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

8.3

290

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

10.8

8.3

W17

ICD-10 Finland

Other fall from one level to another

2.0

8.3

108

562

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

9.5

8.3

Z71.8

ICD-10 Finland

Other specified counselling

1.4

8.3

510

3925

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

8.3

376

J96.0

ICD-10 Finland

Acute respiratory failure

3.3

8.3

124

R4190

NOMESCO Finland

Nutritional therapy

2.3

8.2

323

XKC03

NOMESCO Finland

Water cystometry

2.3

8.2

335

NBH10

NOMESCO Finland

Reduction of dislocation of humeroscapular joint, closed

4.4

8.2

183

Kela drug reimbursment

Lamotrigin and topiramate

4.4

8.2

K02.1

ICD-10 Finland

Caries of dentine

1.3

8.2

1248

10868

WX722

NOMESCO Finland

PEEP

1.8

8.2

129

719

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.4

8.2

109

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.5

8.2

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

3.2

8.1

131

OAA80

SPAT

0.3

8.1

504

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

5.4

8.1

A02BC03

ATC

lansoprazole; oral

1.3

8.1

716

5811

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.3

8.1

330

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

8.1

147

860

G04CA02

ATC

tamsulosin; oral

1.3

8.1

664

5334

33098

ICD-8 Finland

Hereditary neuromuscular disorders, Alii definiti

33.4

8.1

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

8.1

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

8.1

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.2

8.1

374

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.1

8.1

132

P80

ICPC

Personality disorder

6.8

8.1

E83.51

ICD-10 Finland

Hypocalcemia

4.8

8.0

L84

ICD-10 Finland

Corns and callosities

2.1

8.0

435

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.0

8.0

485

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

8.0

173

1060

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.9

8.0

112

597

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.3

8.0

322

RS230

NOMESCO Finland

5.0

8.0

R52.0

ICD-10 Finland

Acute pain

2.3

8.0

314

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

8.0

220

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

7.9

227

1498

K56.0

ICD-10 Finland

Paralytic ileus

3.6

7.9

ZXA00

NOMESCO Finland

Right side

1.3

7.9

678

5478

NH1AD

NOMESCO Finland

Ankle and foot CT

2.7

7.9

197

RS121

NOMESCO Finland

4.7

7.9

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

7.9

107

564

L13.9

ICD-10 Finland

Bullous disorder, unspecified

6.6

7.9

G93.4

ICD-10 Finland

Encephalopathy, unspecified

7.8

7.9

L73

ICPC

Fracture: tibia/fibula

3.5

7.9

102

P98

ICPC

Psychosis NOS/other

5.7

7.8

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.6

7.8

217

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

4.3

7.8

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

4.7

7.8

S76

ICPC

Skin infection other

1.8

7.8

124

696

SPAT1310

SPAT

Counselling related to known health issue

1.3

7.8

731

5983

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

7.0

7.8

E87.5

ICD-10 Finland

Hyperkalaemia

2.6

7.8

211

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

7.7

406

3036

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

7.7

394

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

7.7

470

J01CF05

ATC

flucloxacillin; systemic

2.0

7.7

471

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

7.7

238

RF410

NOMESCO Finland

3.4

7.7

104

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

7.7

125

706

N17

ICPC

Vertigo/dizziness

1.5

7.7

255

1743

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.1

7.7

126

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.6

7.6

196

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.3

7.6

110

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.0

7.6

475

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.8

7.6

160

Y96.9

ICD-10 Finland

Unspecified type of accident

2.7

7.6

190

R52.9

ICD-10 Finland

Pain, unspecified

1.6

7.6

188

1197

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

8.0

7.6

I50.0

ICD-10 Finland

Congestive heart failure

1.6

7.6

211

1384

RS314

NOMESCO Finland

11.9

7.6

W06

ICD-10 Finland

Fall involving bed

4.0

7.6

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.1

7.5

122

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

8.9

7.5

F05.8

ICD-10 Finland

Other delirium

3.8

7.5

I95.9

ICD-10 Finland

Hypotension, unspecified

2.9

7.5

155

QDG30

NOMESCO Finland

Delayed skin closure of surgical wound in lower limb

10.0

7.5

N05AA03

ATC

promazine; systemic

10.0

7.5

TNX30

NOMESCO Finland

Soft bandage, unspecified region

3.1

7.5

128

RF120

NOMESCO Finland

3.2

7.5

117

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

4.3

7.5

SPAT1104

SPAT

Monitoring of emergency patient

1.6

7.5

168

1044

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.9

7.5

149

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

7.1

7.5

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

7.5

102

543

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

7.5

327

L04AA06

ATC

mycophenolic acid; systemic

2.7

7.5

179

S51.0

ICD-10 Finland

Open wound of elbow

3.0

7.5

140

G04BD11

ATC

fesoterodine; oral

2.1

7.5

399

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.5

7.4

222

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

6.5

7.4

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

7.4

321

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.5

7.4

223

M35.7

ICD-10 Finland

Hypermobility syndrome

4.2

7.4

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.2

7.4

113

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

7.4

137

808

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.4

178

1127

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

7.4

101

537

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

7.7

7.4

R44.3

ICD-10 Finland

Hallucinations, unspecified

5.3

7.4

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.6

7.4

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.4

267

1863

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.6

7.3

R4130

NOMESCO Finland

Speech therapy

2.4

7.3

243

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

7.3

131

763

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.1

7.3

405

B01AB05

ATC

enoxaparin; parenteral

1.3

7.3

723

5948

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

7.3

225

3598X

ICD-9 Finland

Muscular dystrophies and other myopathies, Other myopathies

+∞

7.3

NJ3BM

NOMESCO Finland

MRI examination of extremities with 3 Tesla magnet

+∞

7.3

G71

ICD-10 Finland

Primary disorders of muscles

+∞

7.3

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

10.9

7.3

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

9.4

7.3

N94

ICPC

Peripheral neuritis/neuropathy

9.4

7.3

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

5.1

7.2

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

7.2

117

658

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

7.2

100

535

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.4

7.2

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

7.2

454

T00.9

ICD-10 Finland

Multiple superficial injuries, unspecified

4.3

7.2

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

7.2

343

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.7

7.2

170

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.9

7.2

508

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

4.6

7.2

S09.8

ICD-10 Finland

Other specified injuries of head

7.3

7.2

G24.9

ICD-10 Finland

Dystonia, unspecified

7.3

7.2

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.5

7.2

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

7.2

485

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.6

7.2

196

N05AF01

ATC

flupentixol; systemic

2.7

7.2

179

A11CC03

ATC

alfacalcidol; systemic

2.3

7.1

291

N05BA05

ATC

potassium clorazepate; oral

3.7

7.1

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

7.1

153

939

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.5

7.1

204

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

7.1

185

1196

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

3.1

7.1

122

F32.8

ICD-10 Finland

Other depressive episodes

3.2

7.1

111

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.3

7.1

262

C08DA01

ATC

verapamil; systemic

1.9

7.1

533

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

6.0

7.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

7.1

1011

8698

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.0

396

2995

G04BD09

ATC

trospium; oral

2.3

7.0

283

L09

ICPC

Arm symptom/complaint

2.0

7.0

440

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

7.0

123

714

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

3.1

7.0

118

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

4.1

7.0

C07AB02

ATC

metoprolol; systemic

1.3

7.0

548

4368

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.4

7.0

219

SPAT1244

SPAT

Occupational therapy

3.3

7.0

102

G31.0

ICD-10 Finland

Circumscribed brain atrophy

4.9

7.0

U05

ICPC

Urination problems other

1.8

7.0

117

670

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.8

6.9

107

593

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

6.3

6.9

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

2.3

6.9

250

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

7.5

6.9

A10BH05

ATC

linagliptin; oral

1.7

6.9

127

748

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

6.9

423

A10BH01

ATC

sitagliptin; oral

1.5

6.9

224

1525

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

13.8

6.9

G61.8

ICD-10 Finland

Other inflammatory polyneuropathies

13.8

6.9

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

13.8

6.9

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

6.9

125

734

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.8

6.8

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.1

6.8

109

ZX120

NOMESCO Finland

Intravenous

1.5

6.8

213

1439

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.7

6.8

165

Y94.8

ICD-10 Finland

Other leisure activity accident

2.2

6.8

319

R26.0

ICD-10 Finland

Ataxic gait

6.7

6.8

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

10.9

6.8

ZYY79

SPAT

10.9

6.8

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

10.9

6.8

M60.0

ICD-10 Finland

Infective myositis

10.9

6.8

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.8

6.8

143

N06AX22

ATC

agomelatine; oral

2.7

6.8

166

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.1

6.8

356

R40.0

ICD-10 Finland

Somnolence

6.1

6.8

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

4.5

6.8

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.3

6.8

N05AC01

ATC

periciazine; systemic

5.7

6.7

K92.1

ICD-10 Finland

Melaena

1.7

6.7

134

805

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

16.7

6.7

WX290

NOMESCO Finland

Other blockade of nerve

1.3

6.7

875

7431

Y34

ICD-10 Finland

Unspecified event, undetermined intent

4.7

6.7

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

6.7

177

1149

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

22.6

6.7

SPAT1255

SPAT

Intravenous administration of medicine

1.6

6.7

160

1016

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

6.7

130

779

SPAT1138

SPAT

Guidance concerning bowel function

2.6

6.6

169

ZXA05

NOMESCO Finland

Left side

1.3

6.6

620

5057

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

6.6

213

M04AA01

ATC

allopurinol; systemic

1.4

6.6

355

2663

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.2

6.6

101

Z43.5

ICD-10 Finland

Attention to cystostomy

4.2

6.6

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

5.5

6.6

RF420

NOMESCO Finland

2.9

6.6

133

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

12.3

6.6

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

6.6

286

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.1

6.6

107

XF404

NOMESCO Finland

Ambulatory ECG

1.5

6.6

223

1533

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.1

6.6

320

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

6.5

152

955

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

10.0

6.5

N06DX01

ATC

memantine; oral

1.6

6.5

177

1158

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

6.5

540

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

4.8

6.5

M54.3

ICD-10 Finland

Sciatica

1.7

6.5

122

724

J01CA08

ATC

pivmecillinam; oral

1.3

6.5

746

6243

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.1

6.5

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

5.0

6.5

30088

ICD-8 Finland

Neuroses, Other

5.0

6.5

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

5.0

6.5

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

6.5

135

825

29530

ICD-8 Finland

Schizophrenia, Paranoid type

4.5

6.5

N05BB01

ATC

hydroxyzine; systemic

1.7

6.5

138

848

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

3.1

6.4

103

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.0

6.4

109

N07BA03

ATC

varenicline; oral

1.8

6.4

536

R1260

NOMESCO Finland

Evaluation of communicative skills

2.4

6.4

211

B17.1

ICD-10 Finland

Acute hepatitis C

14.3

6.4

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

14.3

6.4

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

6.4

180

1189

D01AC02

ATC

miconazole; topical

1.5

6.4

202

1368

30041

ICD-8 Finland

Neuroses, Depressiva

2.7

6.4

144

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.4

6.4

212

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

8.2

6.3

R25.3

ICD-10 Finland

Fasciculation

8.2

6.3

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2.0

6.3

360

R5110

SPAT

2.1

6.3

312

N07XX02

ATC

riluzole; oral

11.0

6.3

V03AB30

ATC

3.5

6.3

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

6.3

151

959

G12.9

ICD-10 Finland

Spinal muscular atrophy, unspecified

9.3

6.3

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

9.3

6.3

NCM10

NOMESCO Finland

Fasciotomy of forearm

9.3

6.3

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

6.3

116

684

S42.3

ICD-10 Finland

Fracture of shaft of humerus

2.9

6.3

125

NF1DA

NOMESCO Finland

X-ray of hips

2.3

6.3

246

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.4

6.3

218

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

6.3

208

1424

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.8

6.3

G71.1

ICD-10 Finland

Myotonic disorders

+∞

6.2

G70.28

ICD-10 Finland

Other congenital and developmental myasthenia

+∞

6.2

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

6.2

486

3863

SPAT1281

SPAT

Other administrative function

1.5

6.2

180

1197

RF432

NOMESCO Finland

26.7

6.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

6.2

1046

9124

E23.00

ICD-10 Finland

Panhypopituitarism

4.8

6.2

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.0

6.2

106

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

6.2

434

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.0

6.2

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

6.2

129

789

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

6.2

234

1646

S32.4

ICD-10 Finland

Fracture of acetabulum

3.5

6.2

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

5.0

6.2

N05AX13

ATC

paliperidone; systemic

5.0

6.2

29599

ICD-8 Finland

Schizophrenia, Unspecified type

3.9

6.2

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

3.8

6.2

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

6.2

140

875

D07AB08

ATC

desonide; topical

1.5

6.2

231

1625

S14.3

ICD-10 Finland

Injury of brachial plexus

6.3

6.2

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

5.7

6.1

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

6.1

340

2566

T82

ICPC

Obesity

2.0

6.1

336

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

7.7

6.1

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

7.7

6.1

F60.2

ICD-10 Finland

Dissocial personality disorder

7.7

6.1

D07XC01

ATC

betamethasone, combinations; topical

1.4

6.1

273

1986

P06

ICPC

Sleep disturbance

1.5

6.1

193

1307

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

6.1

519

M48.9

ICD-10 Finland

Spondylopathy, unspecified

4.0

6.1

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.4

6.1

197

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

6.1

475

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.7

6.1

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.4

6.1

186

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

6.1

586

4794

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.3

6.0

237

L60.0

ICD-10 Finland

Ingrowing nail

1.8

6.0

511

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

6.7

6.0

F44.4

ICD-10 Finland

Dissociative motor disorders

10.0

6.0

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

6.0

481

S82.0

ICD-10 Finland

Fracture of patella

2.5

6.0

180

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

6.0

365

2794

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2181

8225

5.93

307.65

5.5

2.1

1783.4

189.8

u/l

30.63

2070

7692

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

985

939

14.56

307.65

3.3

2.2

2078.8

336.2

ug/l

8.94

921

882

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

199

118

17.89

242.38

2.0

1.5

9.7

7.3

u/l

0.63

167

(3023368) Bacteria identified in Blood by Culture

1640

7943

3.13

222.02

5.5

4.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

346

588

6.46

197.69

3.2

2.7

30.6

36.6

umol/l

2.26

293

485

(3003458) Phosphate [Moles/volume] in Serum or Plasma

949

3644

3.26

186.37

6.1

5.9

1.1

1.0

mmol/l

1.32

864

3378

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1043

4421

2.99

170.35

3.8

3.3

0.8

mmol/l

2.98

947

4116

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2154

13476

2.74

160.74

10.5

6.8

1.2

mmol/l

4.57

1795

11317

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1990

12222

2.60

149.94

10.1

6.1

1.2

mmol/l

10.28

1831

11013

(3024561) Albumin [Mass/volume] in Serum or Plasma

1901

11713

2.48

137.71

5.5

4.8

33.0

35.0

g/l

32.67

1722

10861

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1021

4734

2.68

135.85

2.2

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

542

1832

3.35

127.15

4.9

3.8

5.2

kpa

0.82

503

1684

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

524

1742

3.39

126.20

4.9

3.8

1.7

1.9

mmol/l

0.30

408

1270

(3009343) pH of Capillary blood

533

1804

3.33

124.61

5.0

3.8

7.4

0.51

221

(3019309) Folate [Moles/volume] in Red Blood Cells

1106

5525

2.51

124.15

2.1

1.8

1201.7

1171.4

nmol/l

0.44

811

4141

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2059

13763

2.33

115.23

6.9

6.1

11.8

12.2

umol/l

0.39

1925

13054

(3014111) Lactate [Moles/volume] in Serum or Plasma

632

2508

2.88

111.21

9.6

6.7

1.5

1.4

mmol/l

1.97

607

2408

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1414

8255

2.25

107.51

3.3

2.5

60.2

58.1

u/l

0.44

1290

7607

(3026008) Bacteria identified in Urine by Culture

1393

8093

2.25

107.07

3.9

3.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

141

175

8.37

106.24

2.0

1.5

1.3

promille

0.90

118

132

(3013826) Glucose [Moles/volume] in Serum or Plasma

2235

15801

2.30

104.55

8.5

4.9

6.8

mmol/l

0.08

2155

14854

(3020779) Urea [Moles/volume] in Serum or Plasma

636

2617

2.77

103.93

8.1

7.2

12.2

10.4

mmol/l

4.93

595

2481

(3009466) Valproate [Moles/volume] in Serum or Plasma

203

390

5.48

100.89

5.7

4.8

352.4

349.0

umol/l

0.11

175

341

(3012544) pH of Venous blood

662

2827

2.68

100.27

5.8

3.7

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

648

2738

2.70

100.24

5.8

3.6

5.9

5.8

kpa

0.99

616

2651

(3002032) Base excess in Venous blood by calculation

646

2726

2.71

100.18

5.8

3.7

2.0

mmol/l

0.11

545

2174

(3031040) Bacteria [#/volume] in Urine by Automated count

2350

17166

2.30

98.52

6.4

4.7

894.9

1580.9

e6/l

0.38

287

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1659

10616

2.14

96.95

6.0

3.9

69.5

52.5

ng/l

0.79

1411

7795

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

354

1122

3.42

90.68

6.0

4.2

24.7

24.8

mmol/l

0.15

322

1038

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

632

2785

2.57

88.85

2.5

1.8

1.5

10.42

523

2436

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

101

103

10.09

88.40

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1203

7039

2.12

86.28

2.5

2.2

3.1

3.0

mg/l

0.79

986

5954

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2581

20142

2.32

84.20

9.8

7.5

82.2

80.1

u/l

1.25

2419

18926

(3022313) Gas panel - Capillary blood

380

1320

3.13

83.47

5.5

4.0

—

(42870588) Differential panel, method unspecified - Blood

1412

8855

2.04

83.17

6.9

5.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1678

11205

2.02

82.72

2.4

2.0

91.5

93.5

pmol/l

0.90

979

5915

(3032080) INR in Blood by Coagulation assay

1697

11457

2.00

80.20

11.4

10.2

1.2

1.3

inr

2.79

468

3171

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

577

2565

2.52

78.87

2.3

2.1

0.2

g/l

5.10

507

2388

(3003396) Base excess in Arterial blood by calculation

687

3319

2.35

78.03

10.0

7.1

1.6

1.1

mmol/l

1.87

554

2586

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

688

3328

2.35

77.90

10.0

7.1

5.2

5.1

kpa

1.34

658

3160

(3027801) Oxygen [Partial pressure] in Arterial blood

688

3328

2.35

77.90

10.0

7.1

11.1

12.0

kpa

4.64

658

3161

(3024354) Oxygen [Partial pressure] in Venous blood

528

2269

2.58

77.40

5.5

3.0

4.7

4.6

kpa

0.46

494

2190

(3000991) Gas panel - Venous blood

544

2379

2.54

76.84

12.0

8.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

483

2000

2.66

76.29

2.0

1.6

—

(3006504) Eosinophils/100 leukocytes in Blood

1735

11973

1.95

75.09

7.9

6.0

2.6

2.8

6.11

1609

11104

(3007853) Bacteria identified in Skin by Aerobe culture

647

3096

2.36

74.81

2.4

1.8

—

(3019069) Monocytes/100 leukocytes in Blood

1739

12030

1.95

74.50

8.5

6.3

8.7

8.9

0.94

1618

11202

(3037467) Urinalysis macro (dipstick) panel - Urine

2324

17770

2.06

74.22

5.7

4.4

—

(3013115) Eosinophils [#/volume] in Blood

1861

13188

1.95

74.00

8.0

6.0

0.2

e9/l

2.15

1629

11474

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

442

1783

2.71

73.38

1.9

1.7

—

(3006315) Basophils [#/volume] in Blood

1813

12766

1.94

73.14

7.6

5.8

0.0

e9/l

1.87

1591

10947

(3001604) Monocytes [#/volume] in Blood

1804

12705

1.93

72.47

7.6

5.7

0.6

e9/l

4.16

1583

10889

(3028707) Methadone [Presence] in Urine by Screen method

148

292

5.26

71.21

3.5

3.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

1756

12321

1.92

70.65

8.1

6.2

24.9

26.9

10.54

1615

11402

(3022096) Basophils/100 leukocytes in Blood

1682

11641

1.91

70.53

7.9

6.1

0.6

0.7

6.17

1558

10812

(3022948) Iron [Moles/volume] in Serum or Plasma

812

4366

2.14

70.15

2.8

2.5

11.1

12.7

umol/l

8.13

711

4039

(3019198) Lymphocytes [#/volume] in Blood

1832

13065

1.91

69.78

7.7

5.9

1.9

e9/l

0.22

1621

11404

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

135

7.53

68.75

13.3

14.2

778.1

793.8

nmol/l

0.11

130

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

315

1096

3.07

68.55

2.3

1.8

—

(3016502) Oxygen saturation in Arterial blood

615

2980

2.31

68.53

10.6

7.5

94.6

95.5

1.97

592

2860

(3018010) Neutrophils/100 leukocytes in Blood

1726

12133

1.89

68.09

7.8

5.9

60.0

58.0

9.12

1602

11290

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

418

1706

2.66

67.54

1.8

1.5

—

(3019060) Gas panel - Arterial blood

455

1951

2.55

66.38

6.1

4.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

362

1384

2.82

66.36

6.6

3.9

24.0

24.2

mmol/l

0.53

329

1244

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

328

1196

2.94

65.61

2.4

1.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1365

8983

1.89

65.28

3.2

3.3

2.3

2.4

mmol/l

8.84

1124

7753

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1513

10305

1.87

64.81

2.7

2.2

74.7

77.4

nmol/l

2.18

1304

9095

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

641

3237

2.22

64.28

2.9

4.0

267.6

245.9

u/l

2.46

585

3044

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

103

8.34

63.79

2.2

2.9

178.8

102.6

umol/l

0.80

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1307

8537

1.88

63.52

3.5

3.2

2309.6

1743.1

ng/l

1.93

1113

7349

(3004789) Transferrin [Mass/volume] in Serum or Plasma

751

4053

2.11

63.45

2.8

2.5

2.2

2.3

g/l

2.31

662

3747

(3013650) Neutrophils [#/volume] in Blood by Automated count

1990

14842

1.87

63.08

12.0

8.8

4.7

4.2

e9/l

10.70

1758

12881

(3021960) Folate [Moles/volume] in Serum or Plasma

1056

6477

1.93

61.90

1.8

1.6

17.8

20.1

nmol/l

5.00

887

5511

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

326

1234

2.82

60.71

2.3

1.9

2.3

2.2

ug/l

0.08

259

1078

(3026782) Osmolality of Urine

927

5475

1.97

60.54

3.5

2.8

516.3

555.8

mosm/kgh2o

6.49

829

4664

(3036481) Cortisol [Moles/volume] in Serum or Plasma

486

2241

2.37

60.15

2.2

2.1

357.9

371.5

nmol/l

0.69

433

2039

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

540

2621

2.27

59.23

2.8

2.4

15.4

7.3

ug/l

4.37

421

2280

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

707

3826

2.08

58.77

2.9

2.6

20.3

22.6

3.98

580

3259

(3018418) pH of Serum or Plasma

1224

7989

1.85

58.37

5.5

4.0

7.4

0.12

284

1547

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

634

3302

2.14

58.26

2.1

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

631

3306

2.13

56.97

2.0

1.8

—

(3019225) pH of Specimen

546

2705

2.22

56.80

6.2

4.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2104

16261

1.82

56.19

5.1

3.1

70.4

53.7

u/l

5.38

1934

15016

(3003181) Sodium [Moles/volume] in Urine

179

498

3.74

55.40

1.5

1.3

53.9

63.2

mmol/l

1.93

125

399

(3020630) Protein [Mass/volume] in Serum or Plasma

497

2392

2.27

55.37

2.1

2.5

64.7

66.2

g/l

3.44

432

2170

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1494

10488

1.78

54.95

3.4

2.8

174.8

147.8

ug/l

2.64

1326

9575

(3027945) Reticulocytes/100 erythrocytes in Blood

630

3358

2.08

54.08

2.4

2.5

1.9

1.8

1.23

516

2943

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

247

862

3.02

53.17

1.4

1.2

—

(1616796) Gas panel - Central venous blood

202

632

3.34

52.23

3.9

—

(3027315) Oxygen [Partial pressure] in Blood

203

645

3.29

51.18

5.1

4.8

8.5

8.4

kpa

0.25

195

633

(3023520) Reticulocytes [#/volume] in Blood

504

2518

2.18

50.95

2.3

2.5

68.9

68.6

e9/l

0.05

375

1929

(3012501) Base excess in Blood by calculation

202

642

3.29

50.91

5.1

4.8

2.6

2.7

mmol/l

0.17

147

438

(3013290) Carbon dioxide [Partial pressure] in Blood

202

643

3.28

50.78

5.1

4.8

5.0

kpa

0.84

194

632

(3037522) Nuclear Ab [Titer] in Serum

579

3073

2.07

49.92

1.4

1.3

452.0

547.3

titre

0.78

123

644

(3010421) pH of Blood

221

760

3.05

48.75

5.0

4.5

7.4

0.27

194

631

(1001926) Buprenorphine [Presence] in Urine by Screen method

174

518

3.49

48.62

3.8

2.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1198

8106

1.75

48.34

4.4

3.2

56.4

38.2

u/l

5.21

1107

7698

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

374

1684

2.38

48.32

9.2

7.6

24.7

24.9

mmol/l

0.31

366

1671

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

325

1373

2.52

48.27

1.6

1.7

1.6

1.5

g/l

1.33

264

1165

(3004588) Protein electrophoresis panel - Serum or Plasma

421

2001

2.27

47.93

1.9

2.3

—

(3011288) Drugs identified in Urine by Screen method

157

442

3.68

47.71

5.5

3.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

523

2720

2.10

47.41

11.9

7.9

119.9

121.5

g/l

0.88

505

2615

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

140

6.06

47.17

1.1

3.8

0.6

nmol/l

0.48

(3014271) Vancomycin [Susceptibility]

164

5.55

46.13

4.2

3.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

104

220

4.85

46.12

1.6

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

1119

7581

1.72

43.96

4.3

3.3

0.6

0.5

e6/l

0.80

926

5770

(3016879) Cocaine [Presence] in Urine

184

608

3.15

43.41

4.1

2.7

—

(3002582) Erythrocytes [#/volume] in Urine

1198

8306

1.70

42.99

4.3

3.4

47.5

80.2

e6/l

2.15

1000

6438

(3000850) Epithelial cells [#/volume] in Urine

909

5838

1.77

42.97

3.4

2.7

5.5

5.0

e6/l

0.57

832

5140

(3022217) INR in Platelet poor plasma by Coagulation assay

680

3999

1.88

42.92

24.5

27.7

1.4

inr

0.02

550

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

8.96

42.83

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

8.96

42.83

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

8.96

42.83

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

8.96

42.83

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

191

652

3.05

42.62

4.0

2.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

7.78

42.52

2.4

2.1

134.9

142.8

nmol/l

0.21

(3018095) Leukocytes [#/volume] in Urine

1321

9470

1.66

41.28

4.9

3.8

115.1

114.7

e6/l

0.01

1047

6889

(3028300) Cannabinoids [Presence] in Urine

190

659

3.00

41.22

4.0

2.6

—

(3027008) Opiates [Presence] in Urine

189

657

2.99

40.83

4.0

2.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

329

1513

2.31

40.21

12.4

9.2

24.8

24.3

mmol/l

0.97

304

1411

(3042936) Bacteria identified in Isolate by Culture

652

3878

1.85

39.33

2.7

2.0

—

(40767503) Oxygen content in Capillary blood by calculation

177

611

3.01

38.70

3.4

2.5

16.4

16.0

0.54

310

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

176

606

3.01

38.66

1.5

1.4

531.1

553.9

mg/l

0.19

168

568

(4198724)

6.97

38.58

2.1

4.1

—

(3044640) Blood type and Crossmatch panel - Blood

1178

8312

1.65

38.45

3.1

2.5

—

(36304419) Bacteria [Presence] in Urine

1067

7352

1.67

38.13

4.3

3.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

311

1434

2.29

37.70

4.5

3.3

25.2

mmol/l

0.04

305

1389

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

851

5545

1.72

37.36

2.0

1.7

1.4

mg/l

1.22

664

4271

(3015235) Bicarbonate [Moles/volume] in Capillary blood

200

753

2.76

37.28

2.8

3.3

24.7

25.0

mmol/l

0.45

183

657

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

885

5835

1.71

37.18

1.8

1.7

24534153.6

26771584.3

pmol/l

0.04

697

4785

(3013707) Erythrocyte sedimentation rate by Westergren method

2269

18899

1.65

36.79

5.0

4.1

16.3

13.1

mm/h

13.84

2047

17367

(3008152) Bicarbonate [Moles/volume] in Arterial blood

368

1842

2.12

36.35

10.0

6.9

24.6

24.5

mmol/l

0.11

353

1717

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

160

545

3.04

35.80

1.4

4.1

3.8

mmol/l

1.79

148

507

(3004119) Hemoglobin [Mass/volume] in Venous blood

355

1775

2.12

35.12

6.4

3.1

126.8

128.2

g/l

0.54

348

1727

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

397

2072

2.04

35.01

4.0

100.8

96.7

ng/l

0.29

323

1775

(3014576) Chloride [Moles/volume] in Serum or Plasma

598

3583

1.82

34.79

12.0

6.7

103.6

104.3

mmol/l

1.91

587

3494

(3044290) Cell count panel - Cerebral spinal fluid

143

472

3.12

33.78

1.7

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

691

4360

1.74

33.55

2.4

2.1

29.8

30.1

0.61

663

4229

(3013512) EKG study

1099

7888

1.59

32.03

5.0

4.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

115

5.48

31.94

1.9

1.7

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

115

5.48

31.94

15.1

10.8

0.6

mmol/l

0.13

108

(3027944) Amphetamines [Presence] in Urine

170

643

2.73

31.39

3.6

2.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

505

2960

1.83

31.30

3.3

2.7

9.5

9.1

umol/l

0.13

428

2595

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2217

18673

1.58

31.28

4.4

3.8

15.0

14.9

pmol/l

0.66

1971

16733

(3024928) Oxygen saturation in Venous blood

160

597

2.77

30.32

7.3

2.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2835

25491

1.83

30.24

30.1

15.6

29.8

25.9

mg/l

7.47

2582

20504

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

211

906

2.42

29.98

2.7

3.4

2.4

ratio

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

762

5072

1.65

29.87

3.1

3.0

2.5

mmol/l

0.20

634

4443

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

915

6387

1.60

29.51

3.0

2.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

214

933

2.38

29.39

2.7

3.4

53.8

64.2

mg/l

0.53

166

753

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

214

933

2.38

29.39

2.7

3.4

36.7

69.8

mg/l

1.39

167

755

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

141

4.76

28.98

2.7

2.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

351

1896

1.95

27.81

2.6

2.8

10.2

10.6

g/l

1.07

313

1730

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

799

5478

1.61

27.46

5.0

3.9

279.0

586.2

ng/l

1.07

675

4525

(40758558) Short blood count panel - Blood

918

6506

1.57

27.37

8.1

6.7

—

(3008295) Osmolality of Serum or Plasma

278

3.49

27.27

1.4

1.3

283.0

276.6

mosm/kgh2o

1.14

198

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

143

532

2.76

27.26

1.8

1.6

1835.0

607.1

e6/l

0.56

122

438

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

143

532

2.76

27.26

1.8

1.5

14.6

28.1

e6/l

0.53

117

419

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

162

643

2.60

27.18

1.3

1.4

0.2

g/l

0.09

154

612

(3028626) Oxygen [Partial pressure] in Capillary blood

167

683

2.52

26.34

3.8

3.6

8.0

kpa

0.00

162

631

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

4.62

25.92

1.1

—

(3020891) Body temperature

240

1160

2.15

25.72

7.0

4.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2575

22839

1.59

25.54

5.5

4.6

1.9

2.1

mu/l

1.21

2323

20597

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

476

2900

1.75

25.53

5.4

3.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

425

2506

1.80

25.50

1.8

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

161

667

2.49

24.71

1.3

1.4

1.2

g/l

0.12

151

634

(46235355) HIV 1 and 2 tests - Meaningful Use set

543

3483

1.67

24.00

1.9

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

261

1337

2.03

23.96

6.7

2.4

0.7

1.59

255

1278

(3011048) Pyruvate [Moles/volume] in Blood

37.85

23.92

1.2

1.3

79.2

115.8

umol/l

—

(3016038) Potassium [Moles/volume] in Urine

174

3.97

23.74

1.1

1.2

31.2

34.4

mmol/l

0.58

153

(3042517) Benzodiazepines panel - Urine

15.09

23.65

2.2

2.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

185

835

2.29

23.43

1.3

1.2

0.2

0.8

u/ml

1.29

(3019550) Sodium [Moles/volume] in Serum or Plasma

2885

26476

1.75

23.42

35.1

18.4

139.2

139.6

mmol/l

10.67

2827

25761

(3052851) Hemolysis interference index of Serum or Plasma

180

805

2.31

23.30

4.1

3.5

—

(3016018) Differential panel - Cerebral spinal fluid

237

3.48

23.29

2.0

1.6

—

(3047181) Lactate [Moles/volume] in Blood

192

884

2.24

23.20

8.5

6.3

1.6

1.3

mmol/l

2.07

165

777

(3033658) Prothrombin time (PT) actual/Normal

920

6722

1.51

23.15

6.2

4.1

85.1

86.4

0.80

886

6563

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

192

889

2.23

22.88

1.6

168.0

270.0

titre

—

(3021901) Oxygen saturation in Capillary blood

138

553

2.56

22.72

2.8

2.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

213

1036

2.13

22.44

4.2

3.3

0.3

u/ml

0.94

119

599

(3023103) Potassium [Moles/volume] in Serum or Plasma

2885

26541

1.72

22.36

35.1

18.5

4.0

mmol/l

0.93

2827

25780

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

178

3.82

22.22

1.2

1.4

2.1

mmol/l

0.01

168

(3028026) IgM [Mass/volume] in Serum or Plasma

278

1495

1.94

22.18

1.8

1.9

1.1

1.4

g/l

1.62

250

1357

(3035350) Ketones [Presence] in Urine by Test strip

1536

12474

1.44

22.12

4.7

3.8

0.0

estimate

0.50

343

2330

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

283

1534

1.92

22.05

15.9

10.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

149

630

2.43

21.90

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

149

630

2.43

21.90

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

1551

12638

1.43

21.82

4.7

3.8

0.0

estimate

1.08

347

2278

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1495

12103

1.43

21.79

4.9

4.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1535

12491

1.43

21.72

6.1

5.1

0.0

estimate

0.50

357

2371

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

183

3.72

21.37

1.7

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

670

4655

1.55

20.98

3.5

2.9

1.3

1.1

e6/l

0.60

411

2667

(40761535) Cells panel - Urine sediment

379

2290

1.74

20.70

4.5

3.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

130

4.21

20.49

1.9

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

130

4.21

20.49

1.9

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

453

2881

1.66

20.46

1.8

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

181

3.64

20.17

1.8

1.3

—

(3021589) Normoblasts [#/volume] in Blood

1386

11208

1.41

19.62

14.9

9.9

0.0

e9/l

0.03

1149

9148

(3017732) Neutrophils [#/volume] in Blood

298

1708

1.82

19.45

5.4

3.2

4.2

e9/l

0.25

200

1283

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

155

703

2.26

19.42

1.6

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

100

370

2.76

19.32

7.9

6.7

12.0

mg/l

0.01

347

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

368

2253

1.71

19.12

6.0

3.9

1.2

mmol/l

2.98

332

1964

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

392

2442

1.69

19.09

3.2

2.5

93.9

58.1

u/l

0.26

316

2089

(40760888) Immunoglobulin light chains.free panel - Serum

156

715

2.24

19.07

2.6

3.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

114

454

2.57

19.05

1.7

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1053

2.02

18.99

1.6

2.3

9.9

10.3

g/l

0.50

161

887

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

515

3442

1.59

18.93

13.4

7.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1121

1.98

18.74

1.6

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1122

1.98

18.69

1.6

2.3

7.4

g/l

0.02

148

840

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

624

4375

1.53

18.49

3.8

3.0

2.4

2.0

e6/l

0.61

371

2401

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

127

544

2.39

18.17

1.5

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

178

877

2.09

18.13

1.7

2.2

36.3

37.4

g/l

1.25

140

750

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

1120

1.96

18.12

1.6

2.3

3.7

3.8

g/l

0.61

144

805

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

115

472

2.49

18.06

1.3

1.2

4.5

4.6

u/ml

—

(3017181) Myelocytes/100 leukocytes in Blood

354

2191

1.69

17.61

3.9

4.0

1.1

0.9

0.56

124

661

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

222

1196

1.92

17.58

7.6

5.3

1.8

1.6

1.11

206

1119

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1692

14312

1.38

17.56

3.0

2.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

327

1983

1.72

17.54

3.7

3.9

1.0

0.6

0.96

101

466

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1042

1.98

17.47

1.6

2.4

3.2

3.1

g/l

0.90

146

823

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

187

952

2.02

17.43

1.8

2.4

0.4

1.2

g/l

3.55

148

815

(40760892) CBC W Ordered Manual Differential panel - Blood

731

5353

1.47

17.39

5.3

4.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

279

2.91

17.28

2.9

2.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

3.75

17.25

1.2

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

27.67

16.49

1.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

333

2077

1.67

16.05

4.1

0.1

0.94

118

605

(3029937) Albumin [Presence] in Urine by Test strip

888

6833

1.41

15.94

5.2

4.2

0.0

estimate

1.28

324

2246

(3037756) Immunofixation for Serum or Plasma

136

636

2.19

15.86

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

321

2.69

15.85

1.7

1.4

—

(3025159) Blasts/100 leukocytes in Blood

314

1935

1.69

15.84

3.9

4.1

0.0

0.3

0.80

110

500

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

125

3.80

15.64

1.4

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

324

2.67

15.57

1.7

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

9.09

15.55

1.5

1.1

11.4

12.3

u/l

0.07

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

325

2.66

15.47

1.7

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

151

744

2.08

15.40

1.4

1.5

252.3

276.6

ug/g

0.75

440

(3016650) Hepatitis A virus Ab [Presence] in Serum

374

2.53

15.29

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

196

1062

1.90

15.26

1.6

1.9

40.0

38.4

u/l

0.45

175

925

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

393

2592

1.59

15.09

3.0

265.2

228.9

ng/l

0.62

357

2366

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

131

619

2.16

14.90

1.3

1.2

39.5

38.2

u/ml

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

315

2.64

14.80

4.3

3.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

315

2.64

14.80

1.7

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

124

576

2.20

14.72

1.3

1.2

2.0

3.4

u/ml

1.09

(3025468) Yersinia sp identified in Specimen by Organism specific culture

316

2.64

14.71

1.7

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

125

584

2.19

14.63

1.3

1.2

16.8

8.2

u/ml

0.27

(3005988) Vibrio sp identified in Specimen by Organism specific culture

317

2.63

14.62

1.7

1.4

—

(40761536) Microorganisms panel - Urine sediment

340

2182

1.62

14.61

5.1

4.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

468

3245

1.52

14.32

4.3

4.6

33.0

32.5

0.36

317

2122

(3011397) Hemoglobin [Presence] in Urine by Test strip

780

5964

1.40

14.27

4.5

3.7

—

(3006653) Thiamine [Moles/volume] in Blood

129

3.60

14.21

1.2

153.0

139.9

nmol/l

0.77

129

(3037121) Protein [Mass/volume] in Urine

178

960

1.90

14.07

3.0

3.3

0.4

0.3

g/l

0.57

402

(3023410) Appearance of Cerebral spinal fluid

238

2.85

14.06

2.3

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

609

4467

1.45

14.02

1.6

1.5

2.6

g/l

0.01

369

2680

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

153

787

1.99

13.89

1.8

2.3

0.0

g/l

0.00

135

719

(3009508) Creatinine [Moles/volume] in Urine

1055

8508

1.35

13.81

3.6

3.2

6.8

7.6

mmol/l

7.70

854

7091

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

141

707

2.04

13.75

1.5

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

112

514

2.22

13.72

1.3

1.2

—

257.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

159

833

1.96

13.70

1.8

2.3

0.0

g/l

0.76

141

762

(21494755) Public health laboratory ask at order entry panel

1817

0.42

13.60

1.3

1.4

—

(3025941) Bacteria identified in Stool by Culture

227

1335

1.75

13.54

1.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

134

665

2.06

13.44

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

206

1183

1.79

13.33

7.9

5.3

0.9

0.68

194

1106

(3007566) Smooth muscle Ab [Titer] in Serum

134

669

2.05

13.23

1.2

75.0

92.0

titre

0.58

(40761511) CBC panel - Blood by Automated count

2807

26296

1.47

13.06

28.2

14.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

149

778

1.96

12.98

1.8

2.3

0.0

g/l

0.00

135

718

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.30

12.65

1.2

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

287

2.58

12.63

3.1

3.4

62.4

57.8

0.80

179

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.98

12.58

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

128

643

2.03

12.44

1.7

—

(3016330) Potassium [Moles/time] in 24 hour Urine

8.46

12.37

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

137

3.32

12.30

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.82

12.26

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1825

0.45

12.25

1.9

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

127

641

2.02

12.19

2.4

2.2

129.7

127.3

g/l

0.48

106

463

(3039000) Anion gap in Blood

127

641

2.02

12.19

10.4

7.2

12.7

11.1

mmol/l

3.26

115

570

(3018572) Chloride [Moles/volume] in Blood

127

642

2.02

12.14

10.4

7.2

104.3

105.4

mmol/l

1.43

115

571

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1163

9655

1.32

12.08

5.1

4.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

101

3.69

11.93

1.1

629.1

241.0

ng/l

0.33

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.42

11.90

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.16

11.78

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.36

11.68

1.3

1.1

—

(1761868) Lipid panel - Serum or Plasma

640

8219

0.73

11.64

3.4

3.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

149

811

1.88

11.49

1.8

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.03

11.46

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

4.40

11.43

2.1

1.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

7.30

10.98

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2854

27001

1.44

10.87

15.1

10.6

31.9

26.9

u/l

11.38

2745

25928

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

167

961

1.78

10.77

2.5

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

214

1327

1.66

10.53

2.7

3.3

4.4

4.5

pmol/l

0.51

181

1158

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

643

4981

1.36

10.46

1.3

1.2

1.0

1.7

u/ml

2.87

155

1290

(3004809) Band form neutrophils/100 leukocytes in Blood

471

2.09

10.39

3.3

3.5

1.3

1.6

0.33

361

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

102

3.46

10.28

1.2

—

(3044927) Protein electrophoresis panel - Urine

309

2.33

9.95

1.2

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

26.09

9.81

1.1

1.0

—

mmol/l

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

101

509

2.02

9.80

3.8

59.0

58.2

0.24

101

509

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

130

714

1.85

9.79

3.8

3.7

2.1

1.6

mg/l

4.01

115

644

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.84

9.73

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

7.40

9.70

4.4

8.2

—

(4035726)

320

2233

1.48

9.37

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

491

2.01

9.32

1.7

—

(3017509) Phencyclidine [Presence] in Urine

7.03

9.28

2.7

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.83

9.22

1.2

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

110

3.21

9.17

1.1

4.5

83.1

72.3

mg/l

0.26

(3024891) Influenza virus A+B Ag [Presence] in Specimen

119

652

1.86

9.06

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

428

2.06

9.05

1.5

30.4

31.1

g/l

0.18

387

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

119

654

1.85

8.97

1.9

2.0

12.7

11.7

mg/l

0.45

112

597

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

397

2.09

8.90

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.17

8.88

2.9

2.0

15.1

16.3

umol/l

0.21

(3030905) Polymorphonuclear cells [#/volume] in Blood

493

1.98

8.87

3.8

3.4

4.5

4.3

e9/l

0.32

493

(3000494) Fungus identified in Specimen by Culture

408

3011

1.41

8.83

1.7

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

359

2.14

8.79

2.6

2.2

32.5

21.9

mg/l

0.65

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

427

2.04

8.74

1.3

1.2

31.9

45.7

u/ml

0.41

(3035637) Corticotropin [Mass/volume] in Plasma

302

2.24

8.70

1.4

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

463

1.99

8.65

1.3

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

4.77

8.58

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

357

2.13

8.52

1.7

1.8

0.6

0.9

g/l

2.11

270

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

273

2.30

8.51

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

392

2.07

8.43

1.3

1.7

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

122

2.97

8.34

2.2

2.1

104.8

95.5

0.57

116

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

101

540

1.90

8.32

1.7

1.6

—

(3019150) Specific gravity of Urine by Refractometry

692

5588

1.30

8.24

5.2

4.2

1.0

kg/l

0.15

844

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.70

8.17

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

346

2.11

8.01

5.4

6.8

6.7

7.6

mmol/l

1.84

291

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

188

2.52

7.98

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

104

3.10

7.97

1.2

—

(40768797) Stomach Pathology biopsy report

454

3466

1.36

7.96

1.4

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

276

2.23

7.88

3.4

3.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

110

3.02

7.88

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

322

2.14

7.86

1.4

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.85

7.85

1.0

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

100

3.12

7.82

3.0

2.8

28.7

29.4

umol/l

0.10

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

118

678

1.77

7.74

1.4

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1179

0.47

7.71

1.4

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

156

2.65

7.70

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.02

7.66

1.3

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

237

1624

1.50

7.60

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

408

1.98

7.60

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

423

1.96

7.54

1.6

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

153

2.63

7.45

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.41

7.42

2.1

2.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

290

2.16

7.41

1.9

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

127

757

1.70

7.33

5.4

2.6

3.6

g/l

0.18

121

718

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.30

7.21

2.1

2.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

230

2.28

7.12

1.4

1.6

—

(4027681)

128

2.75

7.11

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

296

2.12

7.06

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

534

1.82

7.04

1.7

1.8

6.1

4.5

iu/l

0.39

180

(3026493) Urate [Moles/volume] in Serum or Plasma

842

7096

1.25

6.93

2.9

2.8

4057.0

5773.0

umol/l

0.62

686

6110

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

221

2.28

6.87

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

308

2.07

6.75

1.3

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.02

6.70

1.7

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

269

2.14

6.70

1.9

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.70

6.68

2.4

2.6

0.5

0.6

u/field

0.04

(3011985) Renin [Units/volume] in Plasma

310

2.05

6.65

1.3

1.4

45.8

68.6

mu/l

0.53

270

(3023419) Bacteria identified in Sputum by Culture

373

1.95

6.59

2.0

2.6

—

(3007461) Platelets [#/volume] in Blood

2918

28112

1.35

6.48

42.0

22.8

244.4

243.7

e9/l

0.19

2848

27310

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

208

2.28

6.46

1.3

1.5

26.3

24.2

u/ml

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.08

6.46

1.2

1.1

1570.9

1465.7

miu/ml

0.15

(3024731) MCV [Entitic volume]

2919

28125

1.34

6.46

41.9

22.7

92.1

91.3

17.50

2869

27630

(3010813) Leukocytes [#/volume] in Blood

2920

28137

1.35

6.45

42.2

22.8

7.4

6.8

e9/l

18.92

2852

27228

(3023199) Leukocytes [#/volume] in Pleural fluid

390

1.92

6.45

1.5

1.4

21073.2

1784.9

e6/l

0.95

285

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

362

1.95

6.44

1.3

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

2423

22829

1.24

6.40

30.6

16.8

38.1

39.5

8.57

1367

15522

(3000963) Hemoglobin [Mass/volume] in Blood

2919

28132

1.34

6.39

42.4

22.9

129.0

135.3

g/l

72.97

2866

27642

(3021387) Prolactin [Units/volume] in Serum or Plasma

102

596

1.73

6.37

1.9

1.6

348.5

291.6

mu/l

0.60

546

(3035941) MCH [Entitic mass]

2918

28125

1.34

6.35

41.8

22.6

30.5

30.4

1.98

2868

27629

(44806118)

309

2.03

6.34

1.5

1.6

—

(44790047)

309

2.03

6.34

1.5

1.6

—

(44790049)

309

2.03

6.34

1.5

1.6

—

(44790048)

309

2.03

6.34

1.5

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

2918

28127

1.34

6.33

42.0

22.7

4.3

4.5

e12/l

70.65

2846

27225

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

104

615

1.71

6.24

1.7

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.02

6.22

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

789

6684

1.24

6.09

4.4

3.5

—

(3012441) Differential panel - Pleural fluid

328

1.97

6.07

1.4

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2513

23817

1.24

6.03

24.6

14.7

78.1

77.7

ml/min/173m2

0.31

2198

19701

(3014148) Varicella zoster virus Ab [Titer] in Serum

241

2.13

6.01

1.1

—

(40768806) Pleura Pathology biopsy report

330

1.96

5.97

1.7

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

142

2.48

5.85

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

142

2.48

5.85

1.1

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

347

1.92

5.83

1.1

1.6

1.5

g/l

0.46

311

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.52

5.80

1.5

1.0

—

(4062490)

213

2.18

5.72

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

213

2.18

5.72

1.5

1.4

2.9

g/l

0.07

149

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

109

2.68

5.66

3.7

2.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.89

5.61

2.0

4.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

520

1.73

5.61

6.8

5.8

496.9

639.1

iu/ml

0.14

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

411

1.82

5.54

3.2

3.0

1039.7

1924.3

u/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

354

1.88

5.51

1.5

1.4

40152.7

78765.6

e6/l

0.84

216

(3011412) CD3 cells [#/volume] in Blood

230

2.10

5.49

2.2

2.4

1.1

e9/l

0.22

130

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

147

2.40

5.46

2.1

1.7

1.9

2.4

u/field

0.34

107

(3020682) Albumin/Creatinine [Ratio] in Urine

979

8556

1.21

5.45

4.3

4.0

14.2

9.5

mg/mmol

1.86

616

5495

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.24

5.44

1.1

1.3

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

16.04

5.41

1.9

2.2

27.7

32.2

umol/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

118

2.56

5.37

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

266

2.01

5.37

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

167

2.29

5.37

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

167

2.29

5.37

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

167

2.29

5.37

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

932

8119

1.21

5.36

3.4

3.3

610.2

297.9

mg/l

0.88

606

5230

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.87

5.35

1.2

10.8

407.9

ug/l

0.64

(3027135) IgG subclass 1 [Mass/volume] in Serum

213

2.13

5.32

1.5

1.4

6.3

6.9

g/l

0.63

148

(3024139) IgG subclass 3 [Mass/volume] in Serum

213

2.13

5.32

1.5

1.4

0.4

g/l

0.56

147

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

125

2.49

5.28

2.0

2.5

591.9

1196.6

u/ml

1.96

125

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.86

5.26

1.4

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

441

1.76

5.22

4.3

3.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

368

1.84

5.21

1.3

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

170

2.25

5.16

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

170

2.25

5.16

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

170

2.25

5.16

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

291

1.94

5.16

1.2

1.4

257.5

284.6

pmol/l

0.44

221

(4010399)

243

1803

1.38

5.11

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

281

1.94

4.97

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2481

23632

1.20

4.90

6.9

6.1

40.6

40.5

mmol/mol

0.39

2214

21665

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

207

2.09

4.90

1.4

1.3

22.6

24.3

u/l

0.12

168

(3028433) Virus identified in Specimen by Culture

2.78

4.87

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

175

2.19

4.84

2.5

2.3

753.7

706.8

e6/l

0.14

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

170

2.19

4.74

1.4

2.4

12.4

14.0

0.39

(40768443) Skin Pathology biopsy report

161

1127

1.45

4.74

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

344

2718

1.30

4.73

2.4

2.3

167.0

161.4

ug/g

0.09

269

2146

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.80

4.71

1.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

231

2.01

4.70

1.9

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

231

2.01

4.70

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

231

2.01

4.70

1.9

1.6

—

(3042631) Mycobacterium sp identified in Specimen

396

1.76

4.69

2.3

2.8

—

(3020393) Adenovirus Ag [Presence] in Stool

4.15

4.62

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

428

1.72

4.61

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

582

1.62

4.59

1.6

1.4

8.6

8.3

u/l

0.05

477

(3007463) Buprenorphine [Presence] in Urine

10.02

4.52

14.0

4.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

431

1.71

4.50

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

500

1.66

4.49

1.5

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

613

0.45

4.44

1.6

1.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

119

2.36

4.32

2.5

2.3

49.4

52.1

umol/l

0.16

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

8.91

4.28

1.6

1.0

1.9

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.91

4.17

2.1

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

105

693

1.53

4.16

1.8

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

2.99

4.12

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

257

1.88

4.12

1.3

1.1

72.0

70.3

u/l

0.03

176

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.76

4.08

1.1

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

294

1.82

4.07

1.5

2.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

195

1454

1.36

4.04

2.5

2.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

102

674

1.53

4.03

3.0

3.1

0.9

0.8

nmol/l

0.45

509

(21494815) CD4 cells/100 lymphocytes in Specimen

196

2.00

4.02

1.6

2.4

50.8

47.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

130

2.24

3.99

1.2

1.1

1.3

1.2

u/l

0.13

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

163

2.10

3.97

1.5

2.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

191

2.00

3.92

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.65

3.92

1.1

—

(3019977) pH of Arterial blood

164

2.08

3.91

2.8

2.6

7.4

0.82

(3051651) Icteric interference index of Serum or Plasma

158

2.10

3.87

3.3

3.7

—

(3036489) Thrombin time

136

961

1.43

3.87

3.0

2.2

22.3

21.6

0.71

124

859

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.97

3.84

1.1

1.5

0.5

0.4

ug/l

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

444

1.64

3.83

1.5

1.4

97.3

121.8

u/ml

1.28

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

159

2.09

3.82

1.5

4.7

6.4

u/l

0.29

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

104

700

1.50

3.79

3.9

2.5

215.5

196.5

1.01

664

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.54

3.76

1.2

1.4

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

12.02

3.76

1.0

1.5

1.0

u/field

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

416

1.65

3.74

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

224

1.89

3.68

1.1

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

189

1.97

3.67

1.0

304.3

318.7

ng/l

0.12

118

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.68

3.63

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

230

1789

1.31

3.60

1.3

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

177

1.99

3.58

2.0

18.5

18.6

nmol/l

0.02

165

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

191

1.95

3.57

1.0

39.7

44.5

ng/l

0.33

116

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

191

1.95

3.57

1.0

558.3

657.0

ng/l

0.54

116

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.66

3.56

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

206

1.90

3.53

2.0

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

107

738

1.47

3.49

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

409

1.63

3.47

2.2

873.0

2962.4

u/l

1.10

160

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

473

1.58

3.44

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

861

0.60

3.43

2.1

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

334

1.69

3.41

1.4

1.3

0.6

0.3

nmol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

167

1.99

3.38

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.45

3.38

2.4

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

108

752

1.45

3.36

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

107

745

1.45

3.34

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.03

3.25

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

176

1340

1.33

3.23

1.4

1.3

316.4

227.4

u/ml

0.53

159

1231

(3003338) MCHC [Mass/volume]

2015

21143

0.88

3.22

37.5

20.3

330.7

332.4

g/l

11.74

1982

20928

(40768446) Kidney Pathology biopsy report

103

2.24

3.22

1.6

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

3.19

1.1

1.2

—

(3017569) Oxygen content in Arterial blood

144

2.02

3.15

1.6

2.4

—

(3010503) CD19 cells [#/volume] in Blood

151

2.00

3.14

2.6

2.3

0.2

e9/l

0.05

146

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

263

2121

1.26

3.13

3.6

2.7

58.7

63.2

ml/min/173m2

0.95

120

884

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

549

1.51

3.13

1.3

1.1

—

(4024509)

245

1.77

3.11

1.7

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

291

1.69

3.07

1.4

1.3

—

nmol/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

117

844

1.40

3.04

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

126

1702

0.73

3.04

1.2

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

255

1.74

3.01

2.0

2.1

1.7

2.1

u/field

0.23

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

154

1.96

2.99

1.2

—

(3036180) Methadone [Presence] in Urine

10.01

2.98

1.6

3.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

104

738

1.42

2.97

1.6

0.2

8.7

iu/ml

0.57

157

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

183

1.87

2.96

1.1

1.5

15.6

14.2

umol/l

0.36

171

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

155

1.94

2.94

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

303

1.66

2.92

1.3

—

(3045788) Cell count panel - Pleural fluid

311

1.65

2.91

1.5

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

446

1.54

2.88

1.3

322.9

269.2

u/ml

0.66

270

(3030313) Adrenal Ab [Titer] in Serum

5.39

2.87

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.43

2.70

1.4

1.0

281.3

264.3

pmol/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

6.01

2.70

1.7

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.98

2.69

1.5

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2547

24674

1.14

2.65

5.2

4.7

6.1

6.0

mmol/l

2.33

2243

22194

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.13

2.64

1.2

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

546

1.46

2.63

1.3

1.8

0.8

nmol/l

0.57

449

(3011648) Oxygen content in Venous blood

221

1.73

2.61

4.3

1.8

11.2

11.3

0.05

221

(3036603) Volume of Urine

155

1.88

2.61

1.5

1.4

1401.6

1807.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.19

2.57

1.2

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.15

2.55

1.8

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

309

1.59

2.49

2.9

3.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.47

2.48

1.8

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

195

1.75

2.46

1.1

1.3

—

titre

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.14

2.44

1.2

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.95

2.41

1.2

1.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

131

1.92

2.40

1.3

1.5

59.1

62.9

0.21

105

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.01

2.40

5.2

5.8

—

(40757373) Influenza virus identified in Isolate

2.21

2.37

1.2

1.7

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

6.26

2.37

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

660

1.39

2.36

1.5

1.7

17081.8

15572.2

e6/l

0.12

475

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.51

2.35

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

354

1.53

2.35

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

103

764

1.36

2.33

5.6

4.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.09

2.32

1.4

2.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

672

1.38

2.30

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

554

1.42

2.29

1.4

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

102

759

1.35

2.27

1.3

1.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.62

2.27

1.3

1.1

22.7

16.1

nmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

178

1430

1.26

2.26

1.7

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

149

1.82

2.24

1.2

25.9

17.5

u/l

0.86

125

(3044889) 12 lead EKG panel

1904

18216

1.11

2.22

4.5

4.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

165

1320

1.26

2.18

1.2

90.2

151.6

iu/ml

1.32

462

(3047189) Immunofixation for 24 hour Urine

143

1.82

2.18

1.5

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

143

1.82

2.18

3.5

14.2

—

(3044941) Cell count panel - Synovial fluid

436

1.45

2.14

1.3

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

2.30

2.14

1.4

1.3

19.9

69.4

mu/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

596

1.39

2.13

1.6

1.4

17.8

27.4

iu/l

2.20

501

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

573

6368

0.88

2.12

2.7

3.1

0.7

0.8

ug/l

2.10

394

4303

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.56

2.09

2.0

1.7

129.5

145.4

ng/l

0.20

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

2.06

0.0

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

2.06

0.0

6.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.51

2.05

1.0

1.1

—

(3016228) CD19 cells/100 cells in Blood

1.98

2.05

1.4

2.1

8.8

8.1

0.14

(40768800) Prostate Pathology biopsy report

696

0.67

2.01

1.0

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

3.08

2.01

1.0

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.15

1.98

6.2

7.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

248

1.58

1.98

2.2

2.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

209

1.63

1.97

1.4

1.5

0.2

0.3

nmol/l

0.29

167

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

1.96

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.08

1.96

1.2

1.5

14.9

15.8

pmol/l

0.20

(3042733) HLA Ab [Presence] in Serum

2.03

1.95

5.2

5.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

149

1.75

1.94

1.3

1.8

1.1

nmol/l

1.53

113

(3022145) Colonoscopy Study observation

317

2742

1.17

1.94

1.5

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

266

0.49

1.88

1.4

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

181

1.66

1.88

1.3

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

191

1584

1.22

1.87

2.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

151

1.73

1.86

1.3

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

151

1.73

1.86

1.3

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

251

0.48

1.85

1.3

1.4

—

(3035880) pH of Pleural fluid

182

1.65

1.85

1.4

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

400

1.43

1.84

1.2

1.1

18.5

82.9

iu/ml

1.26

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

237

1.57

1.84

1.0

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

437

3888

1.14

1.84

1.3

34.2

36.7

iu/ml

0.09

135

1225

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

250

0.48

1.83

1.3

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

213

2523

0.83

1.83

1.6

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

249

0.48

1.82

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

249

0.48

1.82

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

223

1.58

1.79

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

224

1.57

1.76

2.1

2.2

758.0

622.5

1.04

143

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.44

1.75

2.7

4.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.34

1.74

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.50

1.74

1.0

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

2.67

1.72

1.0

1.1

—

(3016750) Collection duration of Urine

164

1.65

1.68

2.1

2.0

508.2

487.9

min

0.45

117

(3000012) Reticulocyte production index

149

1.68

1.66

1.3

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.58

1.66

1.1

1.2

15.9

16.1

g/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

165

1.64

2.2

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.03

1.64

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.93

1.64

1.1

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.98

1.64

1.3

2.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.84

1.61

1.7

1.8

6.2

10.3

nmol/l

0.33

(3005570) Glucose [Moles/volume] in Urine

270

1.49

1.61

1.9

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

137

1119

1.23

1.59

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

263

2282

1.17

1.59

2.5

2.2

12.3

13.1

nmol/l

0.76

226

2013

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.00

1.58

2.8

1.7

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.70

1.58

1.0

1.1

—

24.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.20

1.57

1.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

137

1.68

1.55

2.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

137

1.68

1.55

2.4

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

137

1.68

1.55

2.4

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

137

1.68

1.55

2.4

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

605

1.31

1.55

2.0

1.9

201.0

206.2

pmol/l

0.15

572

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.11

1.55

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

207

0.48

1.54

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.98

1.53

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

104

827

1.27

1.53

1.8

38.1

39.9

nmol/l

0.31

797

(3033705) Calcium.ionized [Moles/volume] in Venous blood

382

1.39

1.53

4.0

2.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.34

1.52

5.0

6.1

—

(3001556) Androgen free Index in Serum or Plasma

3.34

1.52

1.0

1.2

—

(3005033) Fetal Nuchal fold Thickness US

205

0.49

1.50

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.86

1.50

1.2

3.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.16

1.50

1.2

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.90

1.49

3.9

2.5

—

(4094501)

709

0.73

1.47

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

342

0.61

1.46

4.4

3.8

45.9

37.8

u/ml

0.15

334

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

320

2838

1.14

1.45

3.1

4.0

15.8

22.0

ug/l

0.47

251

2354

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

269

1.46

1.44

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.13

1.44

1.0

1.2

—

(44806071)

2.61

1.36

1.0

—

(3045414) Leukocytes [Presence] in Urine

136

1131

1.21

1.36

2.1

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

210

0.52

1.36

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

619

1.28

1.34

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.87

1.34

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

488

1.32

1.33

1.4

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.97

1.32

4.4

7.4

—

(3022621) pH of Urine by Test strip

203

1757

1.17

1.31

3.3

3.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2411

24624

0.92

1.30

4.7

4.5

1.4

mmol/l

5.84

2122

22407

(3045424) Erythrocytes [Presence] in Urine

421

1.34

1.29

1.3

1.5

—

(3045716) Anion gap in Serum or Plasma

145

1.59

1.29

1.9

2.4

10.8

9.6

mmol/l

0.40

117

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2329

23816

0.92

1.28

4.2

4.0

1.4

1.3

mmol/l

9.75

2046

21507

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

202

1752

1.16

1.27

2.1

1.9

—

(3033799) Differential panel - Peritoneal fluid

1.79

1.27

3.3

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

107

1.69

1.25

2.8

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

179

1.51

1.23

1.0

1.1

—

(4146454)

313

1.38

1.22

2.3

2.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.04

1.22

3.3

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.72

1.21

4.6

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.72

1.21

4.6

2.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.80

1.21

3.9

6.9

70.0

72.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

157

1.53

1.17

1.6

1.5

—

(3000330) Specific gravity of Urine by Test strip

164

1412

1.17

1.16

5.0

3.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.69

1.13

3.0

2.5

1154.0

780.6

e6/l

—

(40768795) Lymph node Pathology biopsy report

234

0.60

1.13

1.1

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

151

1.53

1.11

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

151

1.53

1.11

1.3

1.7

—

(3017704) Immunofixation for Urine

176

1.48

1.10

1.5

1.6

—

(3025315) Body weight

2.38

1.09

5.8

3.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

839

8859

0.93

1.09

3.6

4.3

21.9

0.03

401

4358

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

140

0.50

1.08

7.0

6.3

—

(3049717) Cytology report of Urine Cyto stain

136

1163

1.18

1.06

2.1

2.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

105

1.62

1.06

2.8

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

105

1.62

1.06

2.8

1.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.12

1.05

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.96

1.03

1.4

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.27

1.03

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

154

1.50

1.03

1.9

2.8

48.0

38.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.74

1.02

1.0

1.1

—

(3014891) Appearance of Pleural fluid

1.84

0.98

1.4

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.97

0.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

345

1.31

0.96

1.2

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2116

20695

1.06

0.95

33.7

19.0

14.2

13.8

21.02

2073

20187

(3035320) C reactive protein [Mass/volume] in Body fluid

174

1.44

0.95

2.4

2.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.77

0.94

1.0

1.1

—

6.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.89

0.94

1.9

1.4

43.3

44.7

umol/l

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

304

0.69

0.92

1.0

1.1

0.2

1.2

u/ml

1.69

126

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

453

0.75

0.92

1.3

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

401

1.28

0.92

1.4

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.67

0.91

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate

101

0.49

0.89

1.4

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

185

1.41

0.89

2.3

1.5

51.3

74.4

umol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

103

0.48

0.89

1.4

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2444

24829

0.94

0.86

4.6

4.5

4.4

4.5

mmol/l

8.87

2168

22758

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

227

2509

0.90

0.85

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

309

0.71

0.84

1.0

1.1

2.3

5.8

u/ml

1.77

155

(3001186) Copper [Moles/volume] in Serum or Plasma

1.76

0.83

1.0

1.1

15.5

16.6

umol/l

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

327

1.29

0.83

1.3

1.6

57.8

62.2

0.25

210

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

146

1.44

0.82

2.9

4.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.61

0.81

1.0

—

(1002224) Polysomnography panel

882

0.84

0.80

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.70

0.80

4.1

7.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

198

1.37

0.80

1.5

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.82

0.79

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.82

0.79

1.0

1.1

108.2

100.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.82

0.79

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.79

0.0

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

138

1563

0.88

0.79

1.1

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

620

1.20

0.78

1.1

4.5

6.5

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

769

0.83

0.77

1.9

1.7

5.8

3.9

mg/l

0.32

554

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.70

0.75

1.0

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.60

0.74

2.1

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

167

1.38

0.73

1.1

1.2

—

(3002256) Pathology report gross observation

310

3344

0.92

0.73

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

2.00

0.72

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.55

0.71

2.8

2.3

887.2

22524.0

e6/l

—

(3014051) Protein [Presence] in Urine by Test strip

599

1.19

0.71

2.6

2.2

—

(3044007) Cell count panel - Peritoneal fluid

1.58

0.71

4.1

2.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.75

0.71

1.0

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.92

0.70

40.8

10.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

490

1.21

0.70

1.2

22.9

46.0

u/l

2.08

422

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1144

11074

1.05

0.69

4.3

5.0

3.8

3.5

ug/l

0.15

997

9898

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

528

1.20

0.69

1.2

1.3

314.2

219.6

miu/ml

0.65

217

(3008536) Aspergillus sp Ab [Presence] in Serum

1.53

0.68

1.4

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

110

1.46

0.68

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

338

1.25

0.67

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

338

1.25

0.67

1.1

1.2

3.3

5.0

u/ml

0.85

152

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

631

1.18

0.67

1.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2509

25407

0.95

0.67

5.1

5.0

2.5

2.7

mmol/l

9.78

2225

23144

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.55

0.67

1.2

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

348

1.24

0.66

1.1

1.2

3.8

3.3

u/ml

0.08

118

(40765096) Chromosome analysis panel by Banding

0.53

0.66

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

128

1.41

0.65

1.1

1.2

1.1

ratio

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

503

0.81

0.63

1.3

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.55

0.62

1.3

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.63

0.62

1.1

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.67

0.61

1.4

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.67

0.61

9.6

4.2

—

(4212803)

1.67

0.61

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

199

0.70

0.61

1.0

0.8

0.4

u/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.60

0.0

1.4

—

(44813793)

141

0.64

0.60

1.1

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.56

0.58

1.1

120.3

102.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.3

—

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

391

3692

1.07

0.58

1.3

1.2

7.1

14.3

u/ml

1.16

134

1398

(3018133) Calcium [Moles/volume] in Urine

1.72

0.57

3.0

2.7

1.7

3.2

mmol/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.48

0.57

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

132

1.37

0.57

1.0

1.6

—

10.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.51

0.56

1.1

1.3

30.0

26.2

—

(3024263) Appearance of Synovial fluid

150

1.34

0.55

1.4

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.62

0.55

16.5

10.9

3.3

5.9

mmol/l

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.48

0.53

1.6

3.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.54

0.53

1.0

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

349

0.80

0.53

1.1

1.4

2.1

u/ml

0.50

139

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

197

1.27

0.51

1.6

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.39

0.50

2.4

2.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.41

0.50

2.6

2.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

156

0.70

0.49

1.0

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

279

0.79

0.48

1.9

3.5

4.0

25.5

nmol/l

0.57

274

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

691

1.13

0.47

2.5

2.3

179.9

97.5

ug/min

0.64

419

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

570

1.14

0.46

2.4

3.3

527.1

818.7

u/ml

0.23

526

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

634

6570

0.96

0.46

1.7

1.6

1.4

mmol/l

4.00

537

5481

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.43

0.46

1.6

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

232

0.77

0.46

1.0

0.9

3.0

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

298

0.80

0.45

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

247

1.22

0.44

1.2

355.8

351.1

nmol/l

0.04

207

(3045142) Bone marrow Pathology biopsy report

307

0.81

0.43

1.0

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

295

0.81

0.42

1.0

1.3

3.0

u/ml

—

118

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

327

3434

0.95

0.41

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.52

0.41

1.0

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

268

1.20

0.40

1.3

177277.7

113343.4

e6/l

0.22

186

(4306422)

334

1.17

0.39

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.39

0.0

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

160

1.25

0.38

2.5

1.5

1.0

g/l

0.37

160

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

261

1.19

0.38

1.3

1.4

14.8

26.4

1.63

162

(3009871) Measles virus Ab [Titer] in Serum

1.32

0.37

1.4

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

161

1.24

0.37

1.3

0.4

1.4

u/ml

0.76

(4015189)

1.39

0.37

4.2

2.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.39

0.37

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

278

0.83

0.36

1.0

1.1

0.4

2.6

u/ml

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

437

0.87

0.34

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

100

1085

0.92

0.34

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.34

0.34

1.2

1.1

—

(3024471) HLA-A [Type]

1.34

0.34

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.33

0.33

1.0

—

(3004451) EKG impression Narrative

146

1.23

0.32

1.1

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

285

1.16

0.32

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

101

1.29

0.31

6.4

4.0

56.8

55.2

0.09

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.30

0.30

3.1

2.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

218

0.82

0.30

1.0

1.1

2.2

3.5

u/ml

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

107

0.75

0.29

1.0

1.6

8.4

10.3

ug/l

—

(3029075) Extractable nuclear Ab panel - Serum

1.32

0.28

1.1

1.0

—

(4268621)

233

1.16

0.27

2.0

2.3

—

(4034850)

832

0.92

0.26

13.9

10.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

225

0.84

0.26

1.3

1.4

58.2

194.0

pmol/l

0.52

(3048879) Bone marrow aspiration report

1.28

0.26

1.7

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

244

1.15

0.25

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.25

0.25

1.6

1.3

10.4

9.1

ug/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

160

1.19

0.25

1.4

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

151

1.19

0.25

4.8

3.5

—

(3000034) Microalbumin [Mass/volume] in Urine

245

1.14

0.24

2.3

3.1

14.2

33.7

mg/l

1.42

191

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.22

0.22

1.0

1.5

120.0

101.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.3

—

(3025130) Human papilloma virus identified in Specimen

177

0.85

0.21

1.6

1.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3024932) HLA-DR beta [Type]

1.25

0.20

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

364

1.10

0.20

3.2

2.6

5.7

881.6

u/ml

0.64

349

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.2

—

(3006462) Nitrate [Presence] in Urine

118

1.19

0.19

5.0

3.7

—

(4211845)

128

1.17

0.18

4.7

3.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

100

1.20

0.18

1.2

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

119

1.18

0.17

1.1

12.1

7.9

iu/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

281

1.10

0.17

1.3

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.76

0.17

3.0

3.1

—

63.9

—

(3020650) Glucose [Presence] in Urine

0.75

0.17

1.2

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

173

0.87

0.16

1.1

1.3

—

(40768804) Tissue Pathology biopsy report

1012

10009

1.02

0.15

2.1

2.2

—

(3020491) Glucose [Moles/volume] in Blood

203

0.89

0.15

1.4

2.6

6.3

7.1

mmol/l

1.06

132

(3034426) Prothrombin time (PT)

1.13

0.15

1.1

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

129

0.85

0.14

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

118

0.85

0.14

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

122

1.15

0.13

1.1

1.0

—

(4281824)

222

0.90

0.13

1.6

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

315

0.92

0.13

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

142

1.13

0.12

1.9

2.1

131.2

133.8

ug/min

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

158

0.89

0.12

1.4

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

493

1.06

0.11

1.2

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

310

1.07

0.09

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.11

0.09

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

217

0.92

0.09

1.3

1.5

—

(3008898) HLA-B27 [Presence]

704

1.04

0.09

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.11

0.09

1.0

1.2

—

118.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

634

0.96

0.08

3.9

3.5

27.8

28.4

mg/l

0.04

400

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

127

1.10

0.08

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.83

0.07

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

667

6723

0.99

0.07

1.3

1.4

—

(21494434) Karyotype in Bone marrow

265

0.94

0.07

1.1

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.88

0.06

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.88

0.06

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

275

1.06

0.06

1.1

1.3

7.8

7.5

mmol/l

0.19

208

(3034274) Bile acid [Moles/volume] in Serum --fasting

173

0.92

0.06

1.1

2.0

8.7

11.5

umol/l

0.28

116

(3002523) Influenza virus A Ag [Presence] in Specimen

315

0.95

0.06

1.1

—

(40768793) Breast Pathology biopsy report

463

1.04

0.06

1.4

1.3

—

(3025577) Chromium [Mass/volume] in Blood

172

0.93

0.06

1.7

2.1

2.3

2.0

ug/l

—

147

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.11

0.05

1.1

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

190

1.05

0.04

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

796

1.02

0.03

2.2

1.9

—

(3000492) Spirometry study

233

2311

1.01

0.03

1.6

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

762

0.98

0.03

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

102

1011

1.01

0.01

2.7

3.3

102.5

5035.8

u/ml

1.10

869

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

116

0.95

0.00

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

176

0.97

0.00

1.1

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

176

0.97

0.00

1.2

12.5

12.2

mmol/l

—

(44806420)

101

0.99

0.00

2.3

2.4

—

(40768441) Liver Pathology biopsy report

171

0.99

0.00

2.1

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.0

—

74.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1740.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.98

0.00

1.6

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

1.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

3.6

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

7.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.9

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MYOPOTHUNS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_MYOPOTHUNS	2.128 [1.88, 2.4]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.218

During the follow-up period (1.1.1998 — 31.12.2019), 4593 out of 11033 females with G6_MYOPOTHUNS died.

Males

Parameter	HR [95% CI]	p-value
G6_MYOPOTHUNS	3.28 [2.85, 3.77]	< 0.001
Birth year	0.98 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 6141 out of 14096 males with G6_MYOPOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_MYOPOTHUNS.

N-year risk	Females	Males
1	0.162%	0.382%
5	1.126%	2.7%
10	2.76%	7.574%
15	5.343%	13.817%
20	10.187%	21.645%

Relationships between endpoints

↥

Index endpoint: G6_MYOPOTHUNS – Other and unspecified myopathies

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified myopathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints